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Abstract 
Post-transcriptional regulation of Circadian rhythm: Involvement of the         
CCR4-NOT complex 
Circadian clocks are an endogenous internal timekeeping mechanism that drive the 
rhythmic expression of genes, controlling the 24 hr oscillatory pattern in behavior and 
physiology. These cell-autonomous clocks synchronize to external factors primarily 
light; allowing organisms to anticipate, adapt, and coordinate their biology to the daily 
light/dark cycle. Post-transcriptional mechanisms have recently been shown to play an 
essential role in regulating mRNA and protein oscillations in a time-dependent manner. 
mRNA stability/decay control through poly(A) tail length modulation is one such 
mechanism. Poly (A) tail shortening results in mRNA destabilization, subsequent decay, 
and translational repression. The major deadenylase complex in the cytoplasm is the 
CCR4-NOT complex, which is essential for regulating gene homeostasis by modulating 
RNA metabolism on multiple fronts primarily mRNA decay. In this thesis, we examine 
the role of the CCR4-NOT complex in regulating circadian clocks by focusing on 
CNOT1, the scaffold protein. Cnot1 mRNA exhibits a constantly high expression in the 
mouse superchiasmatic nucleus (SCN) as well as a rhythmic protein and mRNA pattern 
in the mouse liver with peak expression at the early morning. Cnot1 deficiency in mice 
results in elongation of circadian period and alteration in mRNA and protein expression 
patterns of various clock genes, mainly Per2. The recruitment of CNOT1 to Per2 mRNA 
is mediated through Zfp36L1 (BRF1), which itself oscillates in antiphase with Per2 
mRNA. Upon BRF1 knockdown, Per2 mRNA is stabilized. Taken together, this suggests 
that CNOT1 plays a role in tuning and regulating the mammalian circadian clock and 
circadian behavior. 
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1. Chapter 1.  Introduction 
 
1.1 Introduction to the Circadian Clock 
Behavioural, physiological, and cognitive cycles such as sleep-wake, feeding-fasting, 
activity-rest, hormone secretion, and energy metabolism are controlled by an endogenous 
internal timekeeping mechanism referred to as circadian clock. This vital biological timing 
system is conserved throughout the phylogenetic tree from unicellular organisms, such as 
cyanobacteria, to plants and mammals. It provides organisms with the ability to quickly 
anticipate, adapt, and coordinate their biology at a molecular level via regulating gene 
expression and consequently their behaviour with that of the constantly changing 
environment (Kondo & Ishiura 2000).  The circadian clock synchronizes to external 
environmental cues, Zeitgeber, primarily - light, temperature, and food availability - that arise 
from the predictable daily changes in the light-dark cycles. This results in rhythmic processes 
on a biochemical, molecular, and behavioural level with a periodicity of 24 hours.  For 
example, in humans, digestive activity and blood pressure increases in the morning in 
anticipation of food intake and activity, while the production of melatonin (controlling sleep-
wake cycle) increases in the evening coinciding with sleep.   
Circadian rhythms are genetically encoded by molecular clocks within an organism, 
and consist of three major components that are integral to our understanding of clocks. At the 
core is a central self-sustaining biochemical oscillator or pacemaker, present in nearly every 
cell, which keeps circadian time and generates rhythm even in the absence of external cues. 
These endogenous rhythms have a period ranging from 23-25 hours. In the absence of 
external environmental cues, the clock functions at its own pace, known as “free-running”. 
The second component is an input pathway that receives environmental cues, relays them to 
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the central oscillator, and hence synchronizes the internal clock with that of the external 
environment, in a process known as “entrainment”. The final component of the clock system 
are a series of output pathways to which the 24-hour output rhythms produced by the central 
oscillator are conveyed to regulate the various metabolic, physiological, and behavioural 
processes. (Brown et al. 2012; Buhr & Takahashi 2013; Dibner et al. 2010).  
 
1.2 Anatomical organization of the mammalian clock 
In mammals, circadian clocks are located ubiquitously inside of nearly all cells 
(Balsalobre et al. 1998; Nagoshi et al. 2004; Welsh et al. 2004; Yoo et al. 2004). Cross-talk 
between individual cells of the same tissue results in the formation of tissue-specific clocks, 
ensuring that cells of the same organ oscillate simultaneously and function as a single entity. 
In order to coordinate and synchronize physiological processes within and between multiple 
organs, the mammalian circadian system has evolved into a hierarchical structure of multiple 
oscillators with a centralized pacemaker or master clock located in the suprachiasmatic 
nucleus (SCN) of the hypothalamus (Reppert & Weaver 2002; Lowrey & Takahashi 2004).  
This highly unified circadian network of approximately 20,000 neurons receives direct light 
input from the retina, and a series of signalling cascades is activated resulting in neuronal or 
humoral output. These systemic and endocrine cues relay temporal information to other cells 
and organs, synchronizing and aligning them with the environment (Mohawk & Takashi 
2011; Dibner et al. 2010).  Peripheral clocks in turn regulate tissue-specific local rhythms 
corresponding to individual function of each organ that are independent from that of the SCN 
(Kornmann et al. 2007).  A functional clock in the SCN is needed to control local peripheral 
clocks, and loss of SCN results in desynchronized peripheral clocks (Yoo et al. 2004).  
Furthermore, unlike the SCN clock which is mainly regulated by light; peripheral clocks are 
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regulated by other cues including but not limited to cell metabolism, metabolic state of 
surrounding tissue, and feeding/fasting cycles in addition to the cues from the SCN (Partch et 
al. 2014). 
 
1.3 The molecular clock in mammals 
The basic molecular clock mechanism (Figure 1.1) in the SCN and in peripheral 
tissues consists of a network of transcriptional-translational auto-regulatory loops (TTL) 
which drive the rhythmic expression of core clock components (Reppert & Weaver 2002). 
Core clock components of the molecular clock network are defined as genes whose protein 
products are necessary for the generation, regulation, and maintenance of circadian rhythms 
within individual cells (Takahashi 2004). These rhythmic changes in gene expression 
translate to rhythmic changes in behaviour and physiology.  
The core TTL of the molecular clock consists of four integral proteins: two activators 
(CLOCK and BMAL1) and two repressors (PER and CRY). CLOCK and BMAL1 are basic 
helix-loop-helix (HLH), Period-Arntl-Single minded (PAS) transcription factors that 
heterodimerize and bind to the E-box cis regulatory enhancer sequences within the promoters 
of the repressors Per (Per1, Per2, Per3) and Cry (Cry1 and Cry2) genes, as well as other 
clock-controlled output genes (ccgs), activating their transcription. Per and Cry mRNAs upon 
transcription, are translated in the cytoplasm, and form multimeric protein complexes (Ko & 
Takahashi 2006). As soon as sufficient amounts of PER and CRY proteins have accumulated, 
they are phosphorylated by the casein kinases CK1δ/ε and translocate into the nucleus 
(Lowrey et al. 2000; Akashi et al, 2002). Once in the nucleus, the PER/CRY heterodimer 
repress the activity of BMAL1/CLOCK complex, and inhibit further transcription of their 
own genes as well as other ccgs (Gekakis et al. 1998; Kume et al. 1999; Shearman et al. 
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2000; Sato et al. 2006). The repression on BMAL1/CLOCK complex is relieved as PER and 
CRY proteins are degraded by ubiquitin (Ub) dependent pathways.  The E3-ubiquitin ligase 
FBXL3 promotes ubiquitination and proteasomal degradation of CRY proteins (Siepka et al, 
2007). 
A second TTL mechanism exists through another family of ccgs that are controlled by 
BMAL1/CLOCK complex - retinoic acid-related orphan nuclear receptors (Rev-erbs) and 
Retinoid-related orphan receptors (RORs). RORs and REV-ERBs are nuclear receptors that 
bind to the REV-ERBs/ROR-binding element (RRE) in the promoter region of BMAL1, 
regulating its transcription. RORs binding activates transcription of BMAL1, while Rev-Erb 
inhibits transcription. Together, these two TTL loops operate to regulate the transcription of 
core clock genes, with a period of approximately 24 hours, and forms the molecular basis for 
autonomic clock found in mammalian cells (Ko & Takahashi 2006).  In addition to these well 
studied transcription-translation auto-regulatory feedback loops, post-transcriptional 
mechanisms have been shown to be indispensable for the timing of these loops, as they 
regulate protein turnover as well as translocation back into the nucleus.  
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Figure 1.1 Molecular components of the circadian clock. This diagram illustrates the basic 
transcription-translation loop that mediates the molecular clock. A full description is provided 
in the main text.  Figure adapted from Ko &Takahashi, 2006. 
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1.4 Post-transcriptional regulation of mammalian circadian rhythm 
 
For years, it has been believed that the oscillations observed in circadian rhythm are 
solely due to rhythmic changes in transcription activation/repression cycles controlled by 
transcription regulators. However,  recently it has been shown that only 22% of cycling 
messenger RNA (mRNA) are due to de novo transcription; leaving the mechanism for the 
remaining 78% of cycling mRNA unknown (Koike et al. 2012; Menet et al. 2012). 
Furthermore, up to 50% of proteins exhibit rhythmic protein expression even though more 
than half of them exhibit non-rhythmic mRNA expression (Reddy et al. 2006; Mauvoisin et 
al. 2014). This inconsistency in mRNA and protein expression is not a new idea, given that 
the correlation between them in general can be as low as 40% (Vogel & Marcotte 2012). It is 
worth noting that PER and CRY genes exhibit a several hour delay between their transcript 
production and protein expression (So & Rosbash 1997). Therefore, an important regulatory 
step between transcription of mRNAs and protein expression might be involved in explaining 
the relationship between mRNA levels and rhythmic protein expression or lack of. Hence, 
post-transcriptional mechanisms regulating the life cycle of (pre-) mRNA from decapping, 
splicing, polyadenylation, export to the cytoplasm, stability, deadenylation, degradation, and 
translation are suggested to be involved in circadian regulation. These regulatory mechanisms 
are mediated by ribonucleoprotein complexes that include but not limited to RNA-binding 
proteins (RBPs), ribonucleases, and non-coding RNAs (miRNA, lncRNA, piRNA) 
(Filipowicz et al. 2008; Glisovic et al. 2008; Keene 2010).  Indeed several reports have 
confirmed that several steps in mRNA metabolism can be regulated in a circadian manner, 
therefore explaining the discrepancy observed in circadian gene expression (Robinson et al. 
1988; So & Rosbash 1997; Woo et al. 2010; Woo et al. 2009; Chen et al. 1998; Kim et al. 
2005; Kim et al. 2007; Kwak et al. 2006; Morf et al. 2012; Kojima et al. 2012; Kim et al. 
2015; Fustin et al. 2013).  In this section, I will mainly focus on mRNA stability and Poly (A) 
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tail length dynamics. However a summary of other post-transcriptional regulation steps with 
examples regulating circadian gene expression can be found in Table 1.1, and in these elegant 
reviews (Garbarino-Pico & Green 2007; Kojima et al. 2011; Preußner & Heyd 2016; Cibois 
et al. 2010; Kojima & Green 2015) 
One of the first studies to indicate a role of post-transcriptional regulation of circadian 
gene expression in eukaryotes came from Frish et al. (1994). They showed that the promoter 
of the Drosophila Per was not required for its circadian expression, and that the delivery of 
the promoterless-dPer can restore rhythmic locomotor activity in arrhythmic flies; 
demonstrating a transcription-independent mRNA rhythm of a core clock gene. That being 
said, the amplitude of dPer mRNA rhythm was significantly lower in these transgenic flies 
compared to wild-type, suggesting that transcription plays a pivotal role. So & Rosbash 
(1997) compared the active transcription and the steady-state expression profile of dPer, and 
revealed that the half-life of Per changes throughout the circadian cycle, between twofold and 
fourfold, indicating that the stability of Per mRNA is under circadian control. It was later 
shown, that cycling mRNAs in mammals including Per1, Per2, Per3, and Cry1 exhibit 
changes in their mRNA stability, with being more stable during the rising phase of mRNA 
cycling and less stable during the declining phase. The change in mRNA stability along with 
oscillating transcription, results in rhythmic changes in mRNA levels. (Woo et al. 2010; Woo 
et al. 2009; So & Rosbash 1997; Kim et al. 2015). mRNA stability is regulated through the 
binding of RBPs to conserved sequences within the 3’ UTR of a mRNA. Woo et al (2009, 
2010) found that the RBPs, polypyrimidine tract binding protein 1 (PTBP1) and 
heterogeneous nuclear ribonucleoprotein D (hnRNP D), oscillate in a circadian fashion, and 
that they bind to the 3’UTR of Per2 and Cry1 mRNAs, respectively, leading to their 
degradation.  When the levels of PTBP1 and hnRNP D were reduced by RNAi, Per2 and 
Cry1 mRNA became stabilized, and that reduced their oscillator ability. The hnRNPs K and 
15 
 
D also interact with the 3’UTR of Per3, affecting its mRNA stability. hnRNP K stabilizes 
Per3, while hnRNP D destabilizes it (Kim et al. 2015).  Other RBPs such as LARK (RBM4), 
bind to cis-elements in the Per1 3’UTR, promoting its translation (Kojima et al. 2007). While 
hnRNP Q and PTBP bind to the internal ribosomal entry site (IRES) in the 5’ UTR of Rev-
erba, promoting its translation (Kim et al. 2010). Taken together, these results suggest that 
oscillating levels of cytoplasmic RBPs are responsible for the stability and translation of their 
target mRNAs by binding to regulatory elements in their 5’ and 3’ UTRs, and this determines 
the rhythmic expression patterns of their encoded proteins.  It is imperative to understand the 
destabilization of mRNA and subsequent degradation is not due to the binding of the RBPs 
alone, but rather the recruitment of mRNA decay machineries (discussed later) via these 
RBPs. In rare cases can a RBPs result in immediate decay of mRNA. 
 Another post-transcriptional regulation that is an important determinant for 
translational efficiency and mRNA stability is the length of the poly (A) tail. Regulation of 
poly (A) tail length has been shown to be vital in a variety of biological processes including 
mitotic cell cycle progression, cellular senescence, synaptic plasticity and obesity, so it would 
not be a surprise if it plays a role in circadian gene expression (Wu et al. 1998; Huang et al. 
2002; Groisman et al. 2006, Novoa et al. 2010, Takahashi et al. 2015). Robinson et al (1988) 
showed that one of the ccgs, vasopressin (Avp), expressed solely in the SCN, exhibited daily 
changes in the length of their mRNA poly (A) tail. When the poly (A) tail was shortest at 
night, this corresponded with the lowest transcript levels (Robinson et al. 1988; Uhl & 
Reppert 1986; Cagampang et al. 1994). However, Kojime et al (2012) showed at the genome-
wide level in mouse liver, that the circadian clock controls rhythmic changes in poly (A) tail 
length and that this strongly correlates with rhythmic protein expression, independent of the 
steady-state levels of the mRNA. They demonstrated that longer poly (A) tail length 
increased translation efficiency, while short poly(A) tail length lead to destabilization, weak 
16 
 
translation and protein expression. The dynamics of poly (A) tail length are controlled by 
cytoplasmic polyadenylation complexes and deadenylation complexes, and has been shown 
to be a strong determinant of mRNA stability, translation, and decay (Garneu et al. 2007).  
Recently, it has been shown that one deadenylase, Nocturnin (Noc), is under circadian control 
and exhibits rhythmic mRNA and protein expression patterns (Wang et al. 2001, Baggs & 
Green 2003). However, Noc knockout mice displayed normal circadian rhythms and 
expression of core clock genes, and any changes in poly(A) tail were confined to transcripts 
involved in ribosome functions and oxidative phosphorylation (Green et al. 2007; Kojima et 
al. 2015). This could be the result of the moderate deadenylase activity of Noc, seeing that it 
is not one of the major deadenylase proteins in eukaryotic cells (Gabarino-Pico et al. 2007).   
These results and with the emerging field of post-transcriptional regulation of 
circadian rhythm, prompted us to look at the role of  a major regulatory multisubunit that has 
been shown to be involved in every step of mRNA metabolism from transcription to 
translation, the deadenylase complex - the CCR4-NOT, in relation to circadian rhythm (Shirai 
et al. 2014; Collart 2016).  
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Table 1.1 List of post-transcriptional regulation mechanisms in circadian clock. Table 
adapted from Kojima et al. 2011. 
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2. CCR4-NOT complex  
 
2.1 The CCR4-NOT complex 
 
The Carbon catabolite repression 4 (CCR4)–negative on TATA-less (NOT) complex 
is an evolutionary conserved multi-subunit complex that has been implicated in the regulation 
of various cellular process from transcription in the nucleus to mRNA decay and protein 
stability in the cytoplasm.  The multifaceted role of the CCR4-NOT stems from the fact that 
this complex is composed of at least nine core subunits, with different functionality, as well 
as its association and interaction with other cellular machinery including but not limited to 
the RNA polymerase complex, the Dcp1-Dcp2 RNA decapping complex, exosome complex, 
and RISC complex.  Given its diverse activities, it is not surprising that the complex plays 
important roles in apoptosis, necroptosis, spermatogenesis, heart function, obesity, and cancer 
(Ito, Inoue, et al. 2011; Ito, Takahashi, et al. 2011; Suzuki et al. 2015; Berthet et al. 2004; 
Neely et al. 2010; Takahashi et al. 2015; Hämmerle et al. 2013). It has also been shown that 
the yeast CCR4-NOT complex is required for maintaining gene expression homeostasis for 
more than 85% of the yeast genome. In HeLa cells following the knockdown of the human 
CCR4-NOT complex, cells underwent caspase-dependent apoptosis due to ER-stress induced 
by protein overproduction as the result of stabilized mRNA and enhanced translation (Ito, 
Inoue, et al. 2011; Ito, Takahashi, et al. 2011). Due to its wide network of interacting partners 
and its centrality to maintain gene expression homeostasis, it has emerged as an essential and 
central regulator of mRNA metabolism, normal development, and physiology.   In this 
section, I will give a brief overview of the composition of the complex, known functions of 
each subunits, and its main role as a deadenylase complex regulating eukaryotic mRNA 
decay and turnover. For a more in depth review of the involvement of the CCR4-NOT 
complex in regulating the gene expression pathway check Collart 2016; Doidge et al. 2012; 
Bartlam & Yamamoto 2010; Miller & Reese 2012. 
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2.2 Composition and function of the eukaryotic CCR4-NOT complex 
 
The CCR4-NOT complex is composed of at least nine core subunits: CNOT1, 
CNOT2, CNOT3, CNOT6, CNOT6L, CNOT7, CNOT8, CNOT9, and CNOT10; and 
predominately forms a 2.0 MDa protein complex in HeLa cells (Lau et al. 2009). Among the 
subunits, four of them possess a deadenylase catalytic domain: CNOT6, 6L, 7 and 8. CNOT6 
and CNOT6L belong to the endonuclease-exonuclease-phosphatase (EEP) family containing 
a DNase1-like domain; while CNOT7 and CNOT8 belong to the DEDD (Asp-Glu-Asp-Asp) 
family that contains RNaseD-like domains (Shirai et al, 2014). The functional difference 
between these two subgroups of deadenylase subunits is unclear, however, it is worth noting 
that the depletion of CNOT6/6L or CNOT7/8 affected different sets of genes (Mittal et al. 
2011). Furthermore, deadenylase subunits from the same family are interchangeable and 
mutually exclusive, competing on the same binding site – CNOT7 and CNOT8 bind to 
CNOT1; while CNOT6 and 6L bind to CNOT7 and CNOT8 (Lau et al 2009). Mittal et al 
(2011) further demonstrated through microarray analysis that CNOT6L depletion and not 
CNOT6 had a significant effect on mRNA levels. Furthermore, double knockdown of Cnot6 
and Cnot6l decreased cell proliferation and survival (Mittal et al. 2011). It was also shown 
that CNOT6L influences cell proliferation of murine fibroblasts NIH3T3 cells by regulating 
the stability of the Cdkn1b mRNA (Morita et al. 2007). This points to the notion that CNOT6 
and 6L are important for cell viability at least in cell lines as both Cnot6 KO and Cnot6l KO 
mice are viable and fertile (unpublished). The functional role of CNOT7 and CNOT8 has not 
been fully elucidated, but recent reports have indicated that these two deadenylase proteins 
interact with BTG/Tob proteins (BTG1, BTG2/PC3/Tis21, BTG3/ANA, BTG4/PC3B, Tob1, 
and Tob2) and regulate cell cycle progression, by recruiting the CCR4-NOT complex to 
target mRNAs (Winkler & Balacco 2013; Doidge, Mittal, Aslam & G. Sebastiaan Winkler 
2012; Funakoshi et al. 2007; Aslam et al. 2009). Additionally, Cnot7 KO male mice are 
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infertile and exhibit defects in spermatogenesis and bone formation; while Cnot8 KO mice 
are embryonically lethal (Berthet et al. 2004; Nakamura et al. 2004, unpublished). CNOT1 
interacts with most of the subunits as well as other interacting proteins involved in mRNA 
decay, and therefore functions as the scaffold for the whole complex. Knockdown of CNOT1 
in HeLa cells results in complete dissociation of the complex, compromises its deadenylase 
activity, and results in the degradation of its subunits (Ito, Inoue, et al. 2011; Ito, Takahashi, 
et al. 2011).  In addition, Cnot1 KO mice are embryonically lethal (unpublished). CNOT2 
acts as a tethering subunit binding CNOT3, and functions as a regulatory subunit; its 
depletion in HeLa cells compromises the integrity of the CCR4-NOT complex (Ito, Inoue, et 
al. 2011; Ito, Takahashi, et al. 2011). It has been show that CNOT2 acts as a repressor of 
TATA-less promoters through recruitment of histone deacetylase 3 (HDAC3) indicative of a 
role this complex plays in transcription (Zwartjes et al. 2004; Jayne et al. 2006).  The 
importance of this regulatory subunit stems from the observation that Cnot2 KO mice are 
embryonically lethal (Unpublished). CNOT3 is also another regulatory protein in the 
complex, and it is essential in embryonic development because Cnot3 KO mice were 
embryonically lethally. In addition, Cnot3+/- mice exhibited resistance to high-fat-diet (HFD)-
induced obesity by affecting the stability of mRNAs encoding proteins involved in energy 
metabolism (Morita et al. 2011). As for CNOT9, it has been recently reported to be involved 
in micro-RNA mediated translational repression through its interaction with the RISC 
complex, act as a transcriptional cofactor in RA-induced differentiation of F9 embryonic 
teratocarcinoma cells and in lung development (Mathys et al. 2014; Chen et al. 2014; Hiroi et 
al. 2002). Furthermore, it’s protein structure is quite unique compared to the rest of the 
subunits as it contains six armadillo repeat (ARM) domains that are capable of binding single 
and double stranded oligonucleotides, which could provide an alternative pathway for the 
recruitment of the CCR4-NOT complex to mRNA targets (Mathys et al. 2014; Chen et al. 
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2014; Garces et al. 2007). In addition, Cnot9 KO mice are embryonically lethal, indicative of 
its importance in developmental processes (unpublished). Finally, CNOT10 subunit has not 
been elucidated yet, but it seems to promote the deadenylation activity of the complex as a 
whole in Trypanosomes (Färber et al., 2013). However, CNOT10 is proposed to play a vital 
role in development since Cnot10 KO mice are also embryonically lethal (unpublished). 
Taken together, these results demonstrates that the CCR4-NOT complex plays a pivotal role 
in maintaining normal physiological development of tissues and organisms as a whole. 
 
2.3 Role of the CCR4-NOT Complex in mRNA turnover 
 
The main function of the CCR4-NOT complex is regulation of mRNA decay and 
deadenylation (Collart et al, 2016). The control of mRNA decay is a fundamental step in 
regulating the amount of protein produced, and has been shown previously to be a used 
mechanism in regulating circadian gene expression (Woo et al, 2009; Woo et al, 2009).  
Stability and translation of mRNAs into proteins in eukaryotes depends upon the addition of a 
7-methylguanylate (m7G) cap structure at the 5′-end and a poly (A) tail at the 3’-end of the 
mRNA. The cap is added to the nascent RNA by the capping complex co-transcriptionally, 
while polyadenylation by the nuclear poly (A) polymerases occurs after transcript cleavage in 
the nucleus. The pre-mRNA transcript is cleaved at a site 10-30 nucleotides downstream of 
the poly(A) signal (AAUAAA), and then a poly(A) tail of 200-300 nucleotides long is added 
(Doidge et al. 2012).  Once the mature mRNA enters the cytoplasm, both of these 
modification contribute to the stability of the mRNA by protecting the ends from degradation 
by exoribonuclease enzymes, as well as facilitate translation via the recruitment of the 
poly(A) binding protein (PABP) to the tail and the eIF4E translation initiation factor to the 5’ 
cap (Garneu et al. 2007; Kapp & Lorsh 2004).   
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Changes in poly (A) tail length occur throughout the lifetime of an mRNA; 
cytoplasmic deadenylase shorten poly (A) tails leading to translational repression, 
destabilization of the mRNA and its subsequent decay, while cytoplasmic poly (A) 
polymerase (re)adenylate the mRNA and promote translation. (Goldstrohm & Wickens, 
2008). In eukaryotes, degradation of normal cytoplasmic mRNA involves two distinct 
pathways, both of which are initiated by deadenylation (Figure 2.1). Therefore, it has been 
proposed and confirmed that deadenylation is the rate limiting step of this process (Garneu et 
al. 2007, Decker & Parker 1993). In one pathway, following deadenylation, the 5’-cap is 
hydrolysed by the decapping enzyme complex, DCP1-DPC2, exposing the mRNA to be 
degraded via the nuclease Xrn1 in a 5’-3’ direction. In the second pathway, deadenylation 
leads to the exposure of the 3’ end, and the mRNA body is degraded by the exosome in a 3’-
5’ direction (Goldstrohm & Wickens, 2008).  
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Figure 2.1. The two mRNA degradation pathways. Schematic illustration of the two major 
mRNA degradation pathways, a complete description is provided in the main text. Figure 
adapted from Goldstrohm & Wickens 2008. 
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It has been also shown that deadenylation occurs in a biphasic manner, (Figure 2.2) 
(Yamashita et al. 2005; Chen & Shyu, 2010). In the first phase, the Poly (A) Binding protein 
(PABP) recruits the Pan2-Pan3 deadenylase complex that deadenylates and shortens the 
3’poly (A) tail in a distributive enzymatic manner to approximately 110 nt. This initial phase 
does not lead to mRNA decay, as cytoplasmic poly (A) adenylases can still bind and add 
adenosine residues, extending the tail. In the second phase, the CCR4-NOT complex is 
recruited and it hydrolyses the poly (A) completely, consistent with a processive enzymatic 
digestion. Following deadenylation, the CCR4-NOT complex recruits other complexes 
depending on which pathway is used to degrade the mRNA (Chen & Shyu 2010).  
 
 
Figure 2.2. A model for the biphasic deadenylation mediated decay of cytoplasmic 
mRNA in mammalian cells. Poly(A) Binding protein (PABP) recruits the PAN2-PAN3 
complex to initiate initial phase of deadenylation, while at the same time inhibiting the 
decapping complex (DCP1-DCP2) and the CCR4-NOT complex from binding to the mRNA.  
In the second phase, after appropriate shortening of poly (A) tail, CCR4-NOT is recruited to 
continue the deadenylation process. Figure adapted from Yamashita et al. 2005. 
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The CCR4-NOT complex itself is recruited to specific mRNAs through its interaction 
with various RBPs (Figure 2.3). To date, the number of interacting RBPs found to interact 
with the CCR4-NOT complex and recruit them have not been completely identified, and 
these include the BTG/Tob family, miRNA-induced silencing complexes (miRISCs), fem-
3 binding factor (PUF) proteins, Smaug, tristetrapolin (TTP), and Bicaudal-C (Bic-C), BRF1, 
CPEB2, Raver1, Nanos, and Pumilo (Adachi et al. 2014; Takahashi et al. 2015; Suzuki et al. 
2010; Shirai et al. 2014). 
 
 
Figure 2.3. The Recruitment of the CCR4-NOT complex to mRNA via RBPs. A 
schematic illustration depicting, how a CCR4-NOT complex is recruited to a target mRNA 
through an interaction with an RNA binding protein at the 3’UTR for degradation.  
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2.4 Connection between CCR4-NOT complex and circadian rhythm 
 
A relationship between the CCR4-NOT complex and circadian rhythm was suggested 
in Neurospora. Huang et al, (2013) found that NOT1 interacts with the White Collar 1 (WC1) 
and White-collar 2 (WC2) positive complex (WCC) promoting its stability. NOT1 depletion 
resulted in low levels of WC-1 and WC-2, and a delayed circadian phase as a result of 
increased protein degradation and increased WC activity (Huang et al. 2013).  Similar to what 
was observed in Neurospora, in a genome-wide RNAi screen in human cells, Cnot2 
knockdown resulted in an elongated circadian period and low amplitude of clock-controlled 
luciferase rhythm (Zhang et al. 2009). Furthermore, a mathematical model developed by 
Luck et al. (2014) demonstrate that in order to achieve circadian gene expression and explain 
the discrepancy between transcript abundance and protein abundance, rhythmic degradation 
should be taken into account.  In addition, as mentioned in the previous section, post-
transcriptional mechanisms especially that of mRNA stability have been previously shown to 
regulate circadian gene expression. Taken together, these studies indicate that deadenylation 
and mRNA degradation mechanisms are involved in circadian rhythm regulation, and that 
CCR4-NOT might be the regulatory platform controlling such regulation either 
independently or through the recruitment of RBPs.  Therefore, in this thesis, I will be 
examining the relationship between the CCR4-NOT complex and the circadian clock, and 
elucidate its functional role in cellular and behavioural rhythms.  
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3. Specific Aims 
The main aim of my project is to elucidate the functional role of the CCR4-NOT 
complex in regulating the activity of the circadian clock.  Due to the multifaceted nature of 
the CCR4-NOT complex and its role as a major deadenylase complex regulating mRNA 
degradation, I hypothesize that the CCR4-NOT regulates circadian gene expression by 
modulating mRNA stability and turnover via deadenylation mechanisms. In addition, any 
disruption of the complex as a whole, would result in destabilizing circadian rhythm and 
behaviour. This is based on the notion that deadenylase mechanisms are the rate-limiting step 
in mRNA decay process, and is an essential step in degrading mRNA. 
Research Questions 
1) What is the functional role of the CCR4-NOT complex in regulating circadian rhythms? 
2) What are the molecular mechanisms underlying CCR4-NOT complex regulation of 
core circadian genes and clock controlled genes? 
 
Aim 1: Examine time of day dependence of the composition and activity of the 
CCR4-NOT complex 
 
Aim 2: Examine whether the CCR4-NOT complex regulates circadian behaviour 
and molecular clock network in vivo. 
 
Aim 3. Identify the molecular mechanism underlying CCR4-NOT complex 
regulation of circadian genes 
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2. Chapter 2. Materials and Methods 
 
2.1 Animals 
Cnot1 
Cnot1+/- mice generation has been described previously (Takahashi et al, 2019). Briefly, 
Cnot1 flox mice were generated by homologous recombination in TT2 ES cells in which loxP 
sites flank exons 21 and 22 of the Cnot1gene (accession no. CDB0916K, RIKEN) as 
described previously (http://www2.clst.riken.jp/arg/Methods.html). Primers used for 
detection of wild-type, targeted, and knockout alleles are listed in Table 2.2. 
We backcrossed Cnot1fx/fx mice with C57BL/6J mice for at least ten generations. CamKIIa-
Cre mice that express Cre under the control of the mouse calcium/calmodulin-dependent 
protein kinase II alpha (CamKIIa) gene promoter were used to generate forebrain specific 
knockout mice of Cnot1. To generate forebrain specific knockout mice of Cnot1, we crossed 
Cnot1fx/fx mice with CamKIIa-Cre+/+ mice. Primers used for genotyping of alleles are listed 
in Table 2.2. 
Cnot7 
Cnot7-/- generation has been described previously (Nakamura et al, 2004). We backcrossed 
Cnot7-/- mice with C57BL/6J mice for at least ten generations.  
All mice used were maintained under a 12-hr light/12-hr dark cycle in a temperature-
controlled (22°C) barrier facility with free access to water and normal chow diet (NCD, CA1-
1, CLEA Japan). All experiments were performed using 6-14 weeks old male mice. Mouse 
experiments were approved by the animal experiment committee at the Okinawa Institute of 
Science and Technology Graduate University (OIST). 
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2.2 Genotyping 
Tails from 3 weeks old mice were lysed in 50 ul of DNA extraction lysis buffer overnight in 
56° water bath. Followed by addition of 31 ul of phenol/chloroform. Samples were vortexed, 
centrifuged at 130,000 g for 15 min at 4ºC. 1 ul was supernatant was used as template for 
PCR amplification. All genotyping primers are listed in Table 2.2. 
DNA extraction lysis buffer: 
 5 ul of 10x Extaq buffer 
 5 ul of 5% NP-40 
 1 ul of 10 ug/ul Proteinase K 
 39 ul of double distilled water (ddw) 
PCR mixture: 
 0.5 ul of 10uM of primer (reverse + forward) 
 2 ul of 10 ExTaq buffer 
 2 ul of 2.5 mM dNTP  
 0.1 ul of ExTaq 
 1 ul of template DNA 
 14.4 ul of ddw 
PCR amplification of genomic DNA by cycling for 40 cycles: 
 30 s at 94 °C,  
 30 s at 55 °C,  
 1 min at 72 °C. 
PCR products were run on 2% agarose gel with 2x loading sample buffer. 
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2.3 Wheel Running Assay 
Prior to experimental manipulation, animals were housed and kept under a normal 12-hr 
light/12-hr dark cycle. For wheel running experiments, mice (6-8 weeks of age) were housed 
individually in cages equipped with running wheels (Columbus instruments) with food and 
water available ad libitum. Animals were housed under a normal LD cycle until activity 
rhythms were stably entrained (10-14 days), and subsequently housed under DD conditions 
for at least 21 days. Running wheel activity was recorded using the provided software 
(CLAMS, Columbus Instruments). Circadian period from the running wheel activity data is 
calculated using the chi-square periodogram method by a freely available software developed 
by Dr. Roberto Refinetti’s lab (Refinetti, R., 2004).  
2.4 Tissue Collection 
Mice were maintained under a 12-hr light/12-hr dark cycle for at least two weeks prior to any 
experiment. For 12 hr light/12 hr dark cycle experiments using C57BL/6J mice, the mice 
were sacrificed every 4 hours by cervical dislocation and liver tissue removed. Excised tissue 
were washed with PBS, flash frozen in liquid nitrogen and stored at -80C for further 
processing. For handling during the dark phase, retinas were removed under infrared light, 
and livers were excised. For constant darkness experiments, mice were transferred at CT12 
(7pm) when lights switch off into a constant darkness room for 36hrs. Collection of liver 
tissue began at CT0 every 4 hours for 48hrs. Mice were sacrificed by cervical dislocation, 
retinas removed, and excised livers were washed in PBS, and frozen in liquid nitrogen under 
infrared light. For transgenic mice, tissues were collected every 3hrs in the same manner as 
above.  
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2.5 Laser microdissection of the SCN. 
Laser microdissection of the SCN is as described previously (Yamaguchi et al, 2009). 
Briefly, mice were killed by cervical dislocation, retinas removed under infrared light, 
followed by brain excision in normal light, and frozen on dry ice. 30 µm thick coronal brain 
sections were prepared using a cryostat microtome, and mounted on POL-membrane slides.  
Brain sections were fixed for 3 minutes in an ice-cold mixture of ethanol and acetic acid, then 
rinsed in ice cold water, and stained for 30 seconds in ice-cold water containing 0.05% 
toluidine blue, followed by two washes in ice-cold water. Slides were quickly air dried at 
room temperature until moisture decreased and mounted on the LMD7000 device. SCN 
regions were microdissected and lysed in Trizol reageant (Invitrogen), and total RNA was 
purified using the RNeasy micro kit (Qiagen). This was not done by me. 
2.6 Antibodies  
Antibodies against the following were used: CNOT1, CNOT3, CNOT6L, CNOT8, CNOT6, 
and CNOT9 at a concentration of 1:1000ul 3% skim milk (mouse monoclonal antibodies; 
generated by Bio Matrix Research and Research Center for Advanced Science and 
Technology, The University of Tokyo), CNOT2 (1:1000ul 3% skim milk; #34214S; Cell 
Signaling Technology), CNOT7(1:1000ul 3% skim milk; H00029883-M01A; Abnova) 
BRF1/2 (1:1000ul 3% skim milk; #2119; Cell Signaling Technology), α-tubulin (1:3000ul 
3% skim milk;#T9026; Sigma), PER2 (1:2000ul 3% skim milk, ADI), BMAL1 (1:2000ul 3% 
skim milk;A302-616A; Bethyl Laboratories), 4E-BP1 (1:1000ul 3% skim milk;#9644S, Cell 
Signaling Technology), UPF1 (1:1000ul 3% skim milk; #12040S, Cell Signaling), Pumilo2 
(1:1000ul 3% skim milk; #ab10361, Abcam) and GAPDH (1:3000ul 3% skim milk; #2118; 
Cell Signaling Technology). 
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2.7 RNA extraction 
 
All RNA extraction was done using ISOGEN II (Nippon gene) for total RNA according to 
manufacturer’s protocol.  
For tissue: 100 mg of tissue was homogenised in 1 ml of ISOGEN II in a glass homogenizer. 
Lysate was then transferred to a 2ml tube, where 400ul of RNase free water was added with 
vigorous shaking for 15 seconds and left at room temperature (RT) for 7 min. Followed by 
centrifugation at 130,000 g for 15 minutes at 4 degrees. 500 ul of the supernatant was 
transferred to another 2ml tube and 1 ml of ISOGEN II was added with shaking and left 
standing for 7 min at RT. Then 1ml was transferred into a new 2 ml tube, and 400 ul of 
RNAase free water was added with shaking for 15 seconds followed by 7 minutes at RT. This 
was followed by centrifugation at 130,000 g for 15 min at 4 degrees. 920 ul of supernatant 
was then transferred to another tube and 920 ul of isopropanol (equal volume) was added 
followed by 1 ul of glycogen. Following the addition of the glycogen, samples were shaken 
and left at RT for 7 min. Then centrifuged at 130,000 g for 15 min at 4 degrees. The 
supernatant was discarded, and white pellet was washed with 1 ml of 70% ethanol followed 
by centrifugation at 130,000 g for 5 min at 4 degrees. Ethanol was then removed, and pellet 
was centrifuged again to collect remaining ethanol and discarded. Pellet was dissolved in 40 
ul of RNase free water, and RNA concentrations were measured by nanodrop. Total RNA 
was then stored in -80°C for later use.  
For cells: Medium was removed from cell plates, and cells were washed twice with PBS. 
Then 1ml of ISOGEN II was added directly to the plate followed by scraping of the cells. 
Lysate was then transferred to a 2ml tube and the process of extraction was continued as in 
tissue. 
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 2.8 Quantitative real-time RT-PCR (qRT-PCR) 
 
cDNA was generated using the SuperScript III First-strand synthesis system (Invitrogen) as 
follows:  
Mixture 1: 
 1 ug of total RNA 
 1 ul of  oligo(dT) 12-18 primers 
 4 ul of 2.5mM dNTP 
 Up to 7 ul of ddw 
Mixture 1 was boiled at 65 degrees for 5 minutes followed by at least 1 minute on ice. 
Then mixture 2 was added 
Mixture 2: 
 4 ul of 5x First Strand buffer 
 1 ul of 0.1 M DDT 
 1 ul of RNaseOut 
 1 ul of SuperScript III RT 
Tubes were incubated in PCR thermal cycler with the following conditions: 50ºC for 1 hour 
and 70 ºC for 15 minutes. cDNA was diluted 10 fold with RNase-free water. Generated 
cDNA can be stored in -20.  
For qRT-PCR, reactions were performed using 2.5 ul of cDNA1, 5 ul of SYBR Premix Ex 
Taq(Takara), 0.2 ul of ROX reference dye, 0.2 ul of 10uM primer (forward plus reverse). 
qRT-PCR reactions were performed using primers listed in Table 2.1, and analysed with a 
Viia7 sequence detection system (Applied Biosystems). Each sample was run in three 
technical replicates using the following PCR conditions: 
34 
 
95ºC for 30 seconds 
95ºC for 5 seconds 
60 ºC for 30 seconds 
95ºC for 15 seconds 
60ºC for 1 minute 
95ºC for 15 seconds 
Relative expression of mRNA was determined after normalization to either Gapdh or 36b4 or 
both using the ∆∆Ct method.  One-way Anova were conducted to identify significant daily 
rhythm of each gene with significance levels <0.05.  
2.9 Western blotting  
For liver: 
100 mg of liver was homogenised in TNE buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 
1 mM EDTA, 1% NP40, and 1 mM PMSF) and centrifuged twice at 130,000 g for 15 min at 
4ºC. Protein concentration in the lysate were quantified using Thermofisher BCA assay kit 
(ThermoFisher cat. no 23225). 2ug/ul protein concentrates were dissolved in 1XSDS sample 
buffer containing 0.25% -mercapto-ethanol. Proteins in the lysate were then reduced 
through boiling on heat block for 5 minutes at 95°C and subjected to SDS-polyacrylamide gel 
(SDS-PAGE) electrophoresis for around 30 minutes at 100V till they travel through the 
stacking gel and then applied voltage was increased to 150V till they reach the bottom of the 
gel. Afterwards, proteins separated on the SDS-PAGE were electro-transferred onto 0.45m 
polyvinylidene difluoride membranes (PVDF, Millipore cat no. IPVH00010) at 15V for 70 
minutes using semi-dry transfer system (Biocraft, cat. no. BE-321). Proteins of interest were 
probed with appropriate specific antibodies and then horse radish peroxidase (HRP)-
40 cycles 
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conjugated secondary antibodies against the primary antibodies’ host. Chemiluminescent 
signals were analysed with ImageQuant software using an Image Analyser LAS 4000 mini 
(GE Healthcare, Tokyo). Sequential probing of the membranes with a variety of antibodies 
was performed after inactivation of HRP with 0.1% sodium azide (NaN3), according to the 
antibody manufacturer’s protocol. Protein level was quantified using Image Studio Lite 
software (Li-Cor) and normalized to a-tubulin. For normalization of multiple gels, one 
constant sample was loaded on all gel. This was used to normalize the variation between gels 
differences. 
One-way Anova were used to test for rhythmicity followed by post hoc Tukey analyses to 
determine time of day effects. Two way Anova followed by Sidak’s multiple comparison test 
to compare expression between genotypes as well as test for rhythmicity with a significance 
<0.05. 
For cells: 
For cell culture based protein extraction, 250ul of 1xSDS buffer with 0.25% -mercapto-
ethanol was added directly to 3.5cm dish, scraped, and reduced by boiling at 95º. 
Immunobloting was done as above. 
2.10 Poly (A) Tail Assay 
Poly (A) tail length of Per2 mRNA was measured using Poly (A) Tail-Length Assay Kit 
(Affymetrix) according to the manufacturer’s protocol. Briefly, 1 µg of total RNA was 
incubated with poly(A) polymerase in the presence of guanosine (G) and inosine (I) residues 
to add the GI tail at the 3’-ends of poly(A)-containing RNAs. cDNA was generated with PAT 
(PCR poly (A) test) universal primer and reverse transcriptase using GI-tailed RNA as a 
template. PCR amplification was performed with gene-specific and PAT universal primers 
and HotStart-IT Taq DNA polymerase. 
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For PCR amplification of Per2, we used the following gene-specific primers:  
Forward: 5’ - TGCTAAGAAGTTGACTTCCTAGG - 3’  
Reverse: 5’ TTGCACTGGGTGAAGGTACG -3’ 
Poly (A) tail length was quantified with an Agilent High Sensitivity DNA Kit (Agilent 
Technologies) according to manufacturer’s protocol using an Agilent 2100 Bioanalyzer 
(Agilent Technologies). 
 
2.11 Cell Culture  
Transient transfection: 
HEK293T cells were cultured in DMEM containing 10% fetal bovine serum (FBS). For 
transient transfection, HEK293T cells were transfected using Lipofectamine RNAIMAX 
Transfection Reagent, according to the manufacturer’s protocol. For half-life measurements, 
HEK293 cells were transfected with human BRF1 siRNAs with the following sequences 
(Catalog Number HSS101102 [BRF1 (102)], HSS186138 [BRF1 (138)]; CNOT1 siRNAs 
(ThermoFisher Scientific) and control siRNA for 48 hr. Cells were then treated with 5mg/ml 
actinomycin D (WAK0) for a total of 6 hrs, and samples collected at 0, 3, 6 hr after treatment. 
Retroviral infection: 
Retrovirus (mock and Cre) were produced by transfecting Plate-E cells for 48 hrs using 
TransIT-LT1 transfection reagent (Takara) with 2ug of empty pMX plasmid and 2ug of Cre 
recombinase containing pMX plasmid according to the manufacturer’s protocol. 48 hrs post 
infection, supernatant of Plate-E cells was collected, filtered with 0.45-μm filters, treated with 
polybrene (2 ug per 4 ml cells suspension) and then freshly placed on cultured MEFs (40% 
confluence) and kept for 2 days. Afterwards, MEFs were then trypsinized and cultured in the 
presence of puromycin (1g/ml) for another 2 days to select the successfully infected MEFs. 
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2.12 Preparation of Bait RNA and Analysis of RBPs 
 
Mouse Per2 3’UTR (1887bp) and mouse Bmal1 3’UTR (504 bp) were cloned into the pGL3 
control vector using primers listed in Table 2.3. The addition of the Flag tagged and 
generation of Flag-tagged mouse Per2 3’ -UTR (1887 bp) and Bmal1 3’-UTR (504 bp) bait 
RNA were generated as described previously (Adachi et al., 2014). For identification of Per2 
3’-UTR and Bmal1 3’-UTR binding proteins, livers from WT mice were solubilized in TNE 
buffer for 30 min at 4C. Lysates were incubated with 10 pmol Flag-tagged 3’-UTR bait RNA 
for 1 hr at 4C with rotation and then incubated with ANTI-FLAG M2 Affinity gel for 1 hr at 
4C with rotation. 1XSDS sample buffer was used for elution of immunopreciptate RBPs.  
For sequence-specific competition assay, all antisense-oligonucleotides against 
mouse Per2 mRNA were fully LNA modified and were purchased from Gene Design: Oligo-
1 (5′- GATTATTTAATA -3′), Oligo-2 (5′- GTTATTTTATGA -3′).100 pmol of 
oligonucleotides were incubated with 10 pmol of Flag-tagged Per2_2 3’UTR and Per2_3 
3’UTR bait RNA for 1 hr at 4C followed by incubation with ANTI-FLAG M2 Affinity gel 
for 1 hr at 4C with rotation. The bait RNA-protein complex were lysed in SDS-sample buffer, 
and bait RBPs were analysed by immunoblotting. ‘ 
2.13 Mouse embryonic fibroblasts (MEFs) 
MEFs were prepared from E14-14.5 embryos extracted from pregnant wild-type mice that 
were mating with Cnot1+/ - mice.  The pregnant mice mothers were anaesthetized using 
isoflurane and euthanized by cervical dislocation, then the embryos were retrieved. The head 
and internal organs were carefully removed and discarded. Then, embryos were gently 
dissociated in 0.25% trypsin (Gibco, 15090046) at 37°C for 10-15 minutes to get a 
homogenous suspension. Afterwards, the cells were plated on tissue culture flask in 
Dulbecco's modified Eagle's medium (DMEM) high glucose (FujiFilm cat. no. 043-30085) 
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containing 10% fetal bovine serum (FBS, Gibco cat. no. 10270-098) and 100 U/mL 
Penicillin-Streptomycin (Gibco cat. no. 15140122) cultured at 37°C in a dry incubator with 
5% oxygen until confluency.  
2.14 RNA immunoprecipitation (RIP) assay  
Livers collected from wild type were homogenized in RNAase and protease inhibitor 
containing-TNE buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% NP40, 
RNAase and 1 mM PMSF) and centrifuged twice at 130,000 g for 15 min at 4ºC to remove 
debris. 100ul of the lysates were set aside to be used as total input RNA. Protein 
concentration were quantified using Pierce BCA assay kit (ThermoFisher cat. no 23225) and 
100 ug of protein lysates were incubated with 2 g of Cnot3 antibody (Biomatrix), 2 ug of 
mouse IgG (Santa Cruz), 2 ug of BRF1 (Cell Signaling) and 2 ug Rabbit IgG (Santa cru) for 
1 hour at 4ºC with end-over-end rotation. Afterwards, 1.2 ml of Dynabeads Protein G 
(Invitrogen cat. no. 10007D) were added for 2 hours at 4ºC with end-over-end rotation. 
mRNAs were then immunoprecipitated and isolated using Isogen II (Nippon gene cat. no. 
311 – 07361) according to the manufacturer’s protocol. cDNAs were reverse-transcribed 
from all of RNA using SuperScript Transcriptase III (ThermoFisher cat. no. 18080093) and 
Oligo (dT) 12-18 Primer (ThermoFisher cat. no. 18418012) according to the following 
conditions (50 ºC for 1 hour and 70 ºC for 15 minutes). qPCR reactions on diluted input and 
IP cDNAs were carried out with primers against endogenous mouse Per2 and Bmal1 using 
TB Green™ Premix Ex Taq™ II (Takara cat. no. RR820) with RoxII reference dye as 
internal control and a Viia7 machine (Applied Biosystems). The relative expression data were 
analysed by the ΔΔCt fold change method.  
2.15 Immunoprecipitation (IP) assay 
Liver tissues were collected and then homogenized and solubilized in protease inhibitor 
containing-TNE buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% NP40, 
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and 1 mM PMSF), solubilized for 30 minutes at 4ºC and then debris removal through 
centrifugation twice at 130,000 g for 15 min at 4ºC. 100ul of the lysates were set aside to be 
used as total protein input. Protein concentration were quantified using Pierce BCA assay kit 
(ThermoFisher cat. no 23225) and 10 mg of protein lysates were incubated with 2 g of 
Cnot3 antibody(Biomatrix) and 2 ug of BRF1 (Cell Signalling) for 1 hour at 4ºC with end-
over-end rotation. Additionally, IgGs, derived from the same host as the primary antibodies 
were produced, were also run in parallel with IP antibodies to be used as controls for non-
specific binding. Afterwards, 1.2 ml of Dynabeads Protein G (Invitrogen cat. no. 10007D) 
were added for 2 hours at 4ºC with end-over-end rotation. Immunoprecipitated proteins were 
then resuspended in SDS sample buffer, undergone SDS electrophoresis and western blotting 
as previously described above. For confirmation of protein immunoprecipitation with 
Dynabeads, proteins were immunoblotted with appropriate antibodies against the 
immunoprecipitated protein. Proteins of interest were then detected with appropriate 
antibodies. 
2.16. Actinomycin-D chase experiment 
For half-life measurements of mRNA cells were treated with 5mg/ml actinomycin D 
(WAKO) for a total of 6 hrs, and samples collected at 0, 3, 6 hr after treatment. RNA was 
extracted from these cell using the methods described above. For calculation of mRNA half-
lives, the intercept and the slope of the linear regression line were applied according to the 
formula: LN (0.5/e^intercept)/slope. 
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2.17 Primers 
Table 2.1 Primer sets used for RT-PCR 
Gene name Forward primer (5’-3’) Reverse primer (5’-3’) 
mBmal1 AGGCGTCGGGACAAAATGAACA 
 
TGGGTTGGTGGCACCTCTCA 
 
mPer2 TCCGAGTATATCGTGAAGAACG CAGGATCTTCCCAGAAACCA 
mGapdh CTGCACCACCAACTGCTTAG GTCTTCTGGGTGGCAGTGAT 
m/h36B4 CTCACTGAGATTCGGGATATG CTCCCACCTTGTCTCCAGTC 
mClock CCAGTCAGTTGGTCCATCATT TGGCTCCTAACTGAGCTGAAA 
mCry1 ATCGTGCGCATTTCACATAC TCCGCCATTGAGTTCTATGAT 
mCnot1 AGAACCTGGCTGTGGACCTA TGAGTGTGGCTGTTTGGGTA 
mCnot2 CAGACCCAGGAATGGTACATC GGTGATGCAAATTTGGGATAG 
mCnot3 GCTGGTACCCTGCTTAATGG TCTGCCATGGATTTCAGAGA 
mCnot6 TGTATTGGGAGAATGTGGAACT ACCCCACCAGTGCTCAAATA 
mCnot6l CCTCGCAGAATTTACACCATC TTAAGCTCCGCACTCTACCC 
mCnot7 CCAGGCAGGATCTGACTCAC TGACCACAGTATTTGGCATCA 
mCnot8 GCAGGCTCAGACTCTCTGCT TAGAGGCGCCCACAATACTT 
mCnot9 GTCTGCGCATCATGGAGTC AACCAGTGTCATCCAAGAGGA 
hPER2 TACTCGCTGCACACACACAG TGCTGAGTTTTCTTATTTCTTTGAAC 
hBMAL1 CAGGAAAAATAGGCCGAATG GCGATGACCCTCTTATCCTG 
hGAPDH AGCCACATCGCTCAGACAC GCCCAATACGACCAAATCC 
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Table 2.2 Primer sets used for Genotyping 
 
Mouse line Primer sequence (5’-3’) Expected size 
Cnot1KO 
N1 5’ loxp Fw: 
CCACTGACTTGACACTATTAGTGTGAAAGG 
N1 KO Rv: 
CCAGGTGCTGACAATACTGAGGATAGTCC 
N1 flox arm 5’ Rv: 
CCAGAGCTGTCTAGGCAGACAAGG 
Knockout 
allele: 732 bp 
Wildtype allele: 
279 bp 
Cnot1 
conditional Flox 
N1 5’ loxp Fw:  
 
CCACTGACTTGACACTATTAGTGTGAAAGG 
 
N1 flox arm 5’ Rv:  
 
CCAGAGCTGTCTAGGCAGACAAGG 
 
Knockout 
allele: 492 bp 
Wildtype allele: 
279 bp 
Cre 
Cre 5P: TCGATGCAACGAGTGATGAG 
Cre 3P: TTCGGCTATACGTAACAGGG 
Cre : 482 
Cnot7 KO 
N7-Gety-5’: CTCCACATCTAGACTCCTTGTGCTG 
N7-Gety-3’: CATCTCTTCATCCAGGTTACAAGCC 
Knockout 
allele: 320 
Wildtype allele: 
220 
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Table 2.3 Primer sets used for cloning 3’UTR 
mRNA Primer sequence (5’-3’) Expected 
size 
Bmal1 
Forward: CAGTCTAGAACACTACATTTGCTTTGGC with xba1 
restriction  
Reverse: CTGGAATTCATAGAACAAGGGAAACATTTATT with 
ecoR1 restriction 
504 bp 
Per2 
Forward: ATCCTCTAGACCCTGTCCCCCAGCCAGA with xba1 
restriction site 
Reverse: 
CTGCCAGGGAATTCGAAAATAAAAATATACTTGCTTTATTTA 
with ecor1 restriction 
 
1887 bp 
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3. Chapter 3: Results 
 
3.1 CCR4-NOT subunits exhibit diurnal and circadian rhythms in mouse liver.  
 
The subunits of the CCR4-NOT complex have been previously shown to be 
ubiquitously expressed in the majority of mouse tissues with varying levels of expression in 
particular the liver and brain (Chen et al, 2011). However, whether the expression of the 
complex subunits changes in a time-dependent manner is not known. To explore the temporal 
gene expression pattern of the CCR4-NOT complex subunits and determine whether 
expression cycles throughout the circadian day, I collected liver samples from mice housed 
under 12 hours light-dark (LD) conditions every 4 hours around the clock. I extracted total 
protein from these samples, and assessed protein expression through immunoblotting (Figure 
3.1). 
As seen in Figure 3.1, CCR4-NOT complex subunits are expressed at varying levels 
throughout the daily cycle, with individual subunits exhibiting different time-dependent 
expression. CNOT1, the scaffold protein of the complex, is expressed throughout the cycle, 
however it displays a diurnal pattern peaking in the early morning (ZT0-8) and declining as 
the day/night progresses. While CNOT9 exhibits the opposite diurnal pattern, with high 
expression at night (ZT16 -20) and low expression during the day (ZT0- 8).  CNOT2 and 
CNOT3 which are considered modulatory subunits of the complex display no obvious diurnal 
pattern, but exhibit an overall tendency of constant expression throughout the daily cycle. 
CNOT6L exhibits high expression in the morning- early evening (ZT4-12) and low 
expression at night. CNOT7 peaks in expression at night around ZT16, while CNOT8 
displays high expression in the morning (ZT0-12) and low expression at night (ZT14-20). 
Based on this, it is evident that CNOT1, CNOT6L, CNOT7, CNOT8, and CNOT9 exhibit a 
diurnal expression pattern, while CNOT2 and CNOT3 remain constantly expressed 
44 
 
throughout the day. The observed constitutive expression of the CCR4-NOT complex as a 
whole is suggestive of the necessity of the complex in maintaining gene homeostasis. While 
the differences observed in particular that of deadenylase subunits (CNOT6L, CNOT7, and 
CNOT8) hints towards a possible explanation of how different mRNA transcripts are targeted 
for mRNA decay by the CCR4-NOT complex throughout the daily cycle.  
  
 
Figure 3.1. CCR4-NOT subunits protein expression under 12 hr light/ 12 hr dark 
conditions (LD). Total protein was extracted from mouse liver lysates housed under LD 
conditions, and immunoblotting was performed against CNOT1, CNOT2, CNOT3, CNOT6L, 
CNOT7, CNOT8, CNOT9, and α-tubulin (as loading control). This is a representative blot of 
three independent biological replicates (n=3). ZT: Zeitgeber time. 
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However, to explore whether the CCR4-NOT complex subunits are under circadian 
regulation and that the observed expression pattern is an endogenous property, their 
expression patterns needs to be examined under constant darkness (DD) without 
environmental stimuli. To that end, wildtype mice were initially entrained to a 12 hr LD 
environment for at least two weeks, and then released into constant darkness starting at 7 pm 
when lights are switched off. After 36 hrs, starting from CT0, I collected liver tissue from 3-5 
mice per time point for two full consecutive days (48 hrs).  I extracted total RNA and protein 
and assessed mRNA and protein expression patterns of the CCR4-NOT complex (Figure 3.2 
and Figure 3.3, respectively). 
In Figure 3.2A, under DD conditions, Cnot1 expression in the liver is rhythmic 
(p<0.05) with peak levels in the midday to early evening, CT4-8, and a nadir in the late night 
to early morning, CT20-24, with a ~2 fold difference in amplitude. Likewise, Cnot2 
expression is rhythmic (p<0.05) with around 2 fold difference between its peak level in the 
subjective midday, CT8, and nadir in subjective late night, CT20-24 (Figure 3.2B). Cnot6 
expression cycles throughout the circadian day at a low amplitude but still shows a rhythmic 
pattern (p<0.01) with peak levels in the subjective evening, CT8-12 (Figure 3.2D). Cnot6l 
(Figure 3.2E) and Cnot7 (Figure 3.2F), exhibit a similar rhythmic pattern (p <0.01 and 
p<0.001 for Cnot6l and Cnot7, respectively), with a ~ 2 fold difference in amplitude between 
their peak level in subjective day, CT4-8, and nadir during the subjective night, CT16-24. On 
the other hand, Cnot3, Cnot8, and Cnot9 do not show an apparent rhythmic pattern (p>0.05 
for all) and expression is constant throughout the subjective day and night (Figure 3.2C, G-
H). However, we do observe a trend towards multiple peaks of Cnot3 and Cnot9 during CT8 
and CT20 (Figure 3.2 C, H). Cnot1, Cnot2, Cnot6l, and Cnot7 expression pattern are in phase 
with peak expression the midday-early evening and nadir in the late night, which is 
suggestive of a formation of a smaller CCR4-NOT complex during that time window. 
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Figure 3.2 Relative mRNA expression pattern of CCR4-NOT subunits under constant 
darkness (DD) Relative mRNA expression of  A) Cnot1; B) Cnot2; C) Cnot3; D) Cnot6; E) 
Cnot6l; F) Cnot7; G) Cnot8; and H) Cnot9 normalized against Gapdh and 36B4 using ΔΔCT 
method . One way ANOVA was used to assess rhythmicity. (*p<0.05, **p<0.01, 
***p<0.001; and N.S: not significant). Values are mean ± SEM, n= 3-5. 
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Next I performed immunoblotting on total protein lysates against the components of 
the CCR4-NOT complex to determine whether their protein expression is circadian in nature 
as their mRNA profiles, and see if they exhibit a similar pattern in DD (Figure 3.3) as they 
did under LD conditions. (Figure 3.1).  
 
Figure 3.3 CCR4-NOT subunits protein expression in mouse liver under constant 
darkness Total protein was extracted from mouse liver lysates housed under DD conditions 
for two consecutive cycles, and immunoblotting was performed against CNOT1, CNOT2, 
CNOT3, CNOT6L, CNOT7, CNOT8, and α-tubulin (as loading control). This is a 
representative blot of three independent biological replicates (n=3).  
 
Figure 3.3 shows that CNOT1 exhibits a circadian pattern peaking every 24 hours at 
CT0 and CT20-CT24. CNOT2 and CNOT3 subunits are constantly expressed throughout the 
circadian day.  CNOT6L shows a rhythmic expression with elevated expression during the 
subjective day (CT0-8; CT28-36) than during the subjective night (CT12-20; CT40-44). 
CNOT7 also shows a rhythmic pattern, which is opposite to that of CNOT6L, with high 
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expression at the subjective night (CT12-16; CT32-40), and a nadir during the subjective day. 
CNOT8 is constantly expressed with no major changes in protein expression throughout the 
circadian cycle. When comparing peak mRNA levels with that of protein levels we notice 
that in some of the subunits there is substantial delay. Cnot1 mRNA peaks at CT8, but protein 
levels only reach protein peak by CT20, a 12 hr delay between peaks (Figure 3.2A and Figure 
3.3 respectively). Similarity, Cnot6l mRNA peaks at CT8 (Figure 3.2E) with protein level 
peaking ~ 16-20 hrs later. Cnot7 on the other hand displays very short delay between mRNA 
peak at CT8 (Figure 3.2F) and protein peak at CT12. Cnot2 mRNA was shown to be 
rhythmic with peak mRNA at CT8, however, protein expression was not. These delays 
between steady-state mRNA levels and protein levels is indicative that they are regulated on a 
post-transcriptional and/or a post-translational level.  
 
3.2 Gene expression pattern of CCR4-NOT subunits in the SCN 
 
Seeing that the master clock is located in the SCN, it is essential to know the 
expression pattern of the CCR4-NOT complex subunits in order to examine whether they 
play a functional role in circadian behaviour regulation. Using laser microdissection, SCN 
samples were collected from the brains of mice every 4 hours under DD conditions, and 
quantitative RT-PCR (qRT-PCR) was conducted  for Cnot1, Cnot2, Cnot6l, Cnot6, and 
Cnot7 (Figure 3.4). The collection of the SCN tissue, RNA extraction, and qRT-PCR were 
conducted by Ms. Kono Yuka and Ms. Natomi Sato (members of Dr. Hitoshi Okamura’s lab).  
Of the examined subunits, Cnot7 is the only subunit that displays a rhythmic expression and 
main effect of time of day (p<0.05) with peak expression in the evening (CT8-12) and nadir 
levels in the late night to midday (CT20-4) (Figure 3.4E). 
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Figure 3.4. Temporal mRNA expression pattern of CCR4-NOT subunits in mouse SCN 
under DD conditions. Absolute quantification measured by qRT-PCR of A) Cnot1; B) 
Cnot2; C) Cnot6; D) Cnot6l; and E) Cnot7; normalized against 36B4. Per1 mRNA 
expression was also assessed and graphed on all plots to help in visualisation of rhythmicity. 
One-way Anova was used. Values are means ± SEM; n = 3-5. This experiment was 
conducted by Ms. Kono Yuka and Ms. Natomi Sato (members of Dr. Hitoshi Okamura’s lab). 
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The rhythmic expression of Per1 was in antiphase compared to the expression of 
Cnot7, with greater levels of Per1 expression occurring during the subjective day than night 
(CT0-4). As for Cnot1, Cnot2, Cnot6, and Cnot6l they did not exhibit any significant 
rhythmic expression (p>0.05) but rather a constant expression throughout the subjective day 
and night (Figure 3.4A-D). However, it is worth noting that the examined subunits in 
particular Cnot1 have a relatively high constant expression in the SCN in comparison to Per1 
(Figure 3.4). Based on these results, we can conclude that examined CCR4-NOT complex 
subunits are expressed in the SCN and due to the nature of the complex a possible role in 
regulating circadian behaviour is possible. 
To further confirm the observed expression, we examined the expression of Cnot1 
and Cnot7 using [33P]UTP radiolabelled in situ hybridization at two different time points: 
CT4 and CT12 with Per1 used as a positive control (Figure 3.5). Cnot1 is expressed at both 
time points in the SCN as well as other brain areas including the cerebral cortex, the piriform 
cortex, cortical amygdala, and the hippocampus (Figure 3.5A). Cnot7 is also expressed in the 
SCN at both time points (Figure 3.5C). Furthermore, Cnot7 expression is not limited to the 
SCN but also present in the cerebral cortex, the piriform cortex, and the hippocampus. Per1 
which was used as a positive control is expressed at CT4 but almost completely absent at 
CT12 (Figure 3.5B). The examination of other subunits was not possible at the moment due 
to some difficulties with probe design. The in situ hybridization data confirms the observed 
expression of Cnot1 and Cnot7 in the qRT-PCR data (Figure 3.4A, E). This experiment was 
conducted by Ms. Natomi Sato and Ms. Kono Yuka (members of Dr. Hitoshi Okamura’s lab). 
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Figure 3.5. [33P]UTP radiolabelled in situ hybridization showing expression of Cnot1, 
Cnot7, and Per1 in the SCN. Representative autoradiographs of [33P] UTP labelled in situ 
hybridization showing A) Cnot1 B) Per1; and C) Cnot7 expression in WT mouse SCN 
collected under constant darkness. The red arrows indicate the location of the SCN. Red 
arrows indicate the SCN.  
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3.3 Cnot1 and Cnot7 deficiency elongates circadian period 
 
Based on the previous results that show that components of the CCR4-NOT complex 
are expressed in the SCN at high levels, we examined whether the CCR4-NOT complex 
regulates the circadian clock in vivo by employing the use of CCR4-NOT subunit knockout 
(KO) mice. We chose two different knockout mice lines – Cnot1+/- mice (as homozygotes 
were embryonically lethal) and Cnot7-/-. CNOT1 was chosen because it is the scaffold protein 
of the complex and has been shown to be indispensable for the function and integrity of the 
complex (Ito, Takahashi, et al. 2011). As for CNOT7, it is one of the major deadenylase 
subunits of the complex, and the only subunit examined that exhibited a rhythmic expression 
in the SCN on an mRNA level and on a protein level in the liver under constant darkness. 
Therefore, it was reasoned to be a good candidate. 
Cnot1+/- mice 
This is one of the first studies to use Cnot1+/- mice to analyse the function of CNOT1 
in physiological conditions. Cnot1+/- mice generation is explained in detail in Takahashi et al, 
2019. Upon handling the mice, we noticed that there was a significant difference in body size 
between Cnot1+/- and their wild-type littermates, with Cnot1+/- exhibiting a decrease in total 
body weight (Figure 3.6A-B).  This is consistent with similar report of CCR4-NOT KO mice 
(Morita et al, 2011; Takahashi et al, 2015). To confirm that CNOT1 protein levels are reduced 
in Cnot1+/- we performed immunoblotting against CNOT1 using Cnot1+/- and wild type lysate 
(Figure 3.6C). As Figure 3.6C-D shows, CNOT1 levels were reduced to around 45%. 
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Figure 3.6. Cnot1+/- mice are lean under normal diet. A) Gross appearance of wild-type 
and Cnot1+/- mice 12 weeks of age. B) Cnot1+/- mice weight significantly less than WT mice. 
(n=9 for both genotypes, **p <0.01, unpaired t-test) C) Liver lysates of WT and Cnot1+/- were 
analysed by immunoblotting with antibodies against CNOT1 and α-tubulin showing 
decreased CNOT1 expression. D) Quantification of the immunoblotting data (n=2; * p<0.05, 
unpaired t-test). Values presented as mean ± SEM. 
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To determine the effects of CNOT1 reduction on behavioural rhythmicity we 
monitored the wheel running activity of Cnot1+/- and their WT littermates.  Mice aged 6-8 
weeks were initially housed in cages equipped to measure wheel running activity for 10 days 
in a 12 hr light/12 hr dark cycle and then under constant darkness for at least 21 days (Figure 
3.7A-B). In free-running conditions, Cnot1+/- mice displayed a longer circadian period (n = 7, 
23.96 ± 0.04hr) than that its WT littermate (n = 7, 23.78 ± 0.03hr, p <0.01) (Figure 3.7D).  
In order to rule out the observed changes in circadian behaviour are due to side effects 
of whole body heterozygosity, we generated Cnot1-CamKII-Crefx/+ mice. CamKII is 
expressed mainly in the forebrain which includes the SCN (Tsien et al, 1996). CamKII-Cre 
mice were crossed with Cnot1fx/fx mice to generate Cnot1-CamKII-Crefx/+ mice. Cnot1-
CamKII-Crefx/fx were not used because they exhibited early postnatal lethality primarily due 
to improper formation of the forebrain (communications with Dr. Hoshina Naosuke).  Cnot1-
CamKII-Crefx/+ mice were tested for circadian deficiency and they exhibited a similar 
elongation of circadian period (n=3, 23.9 ± 0.02, p<0.05) (Figure 3.7C-D) .This clearly 
indicates that Cnot1 deficiency affects circadian behaviour as exhibited by an elongation in 
circadian period length. The mechanism behind such elongation will be explored later on in 
the thesis.  
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Figure 3.7. Cnot1 deficiency elongates circadian period. Representative double-plotted 
actograms of A) Wild-type; B) Cnot1+/-  and C) Cnot1-CamKII-Crefx/fx housed in wheel 
running cages for at least 30 days. The 10 days LD period and the 26 days DD period is 
labelled to the right of the actogram. In both LD and DD conditions, time of day is 
represented by grey and black panels above actogram indicating periods of day and night, 
respectively. D) Plotted are the period lengths of individual animals (means ± SEM) of WT, 
Cnot1+/-  and Cnot1-CamKII-Crefx/fx (n=7 for WT and n=7 for Cnot1+/- and n=3 for Cnot1-
CamKII-Crefx/fx , **p<0.01, unpaired t-test).  
56 
 
Cnot7-/-mice 
To determine whether Cnot7 expression in the SCN plays a role in regulating 
circadian behaviour, we examined Cnot7-/- wheel running behaviour. (Figure 3.8). The 
examination of Cnot7-/- circadian phenotype was done by Ms. Aya Shimada from Dr. Hitoshi 
Okamura’s lab. In free-running conditions, Cnot7-/- mice displayed a significantly longer free-
running period (n=7, 23.92 ± 0.02 h) than that of Cnot7+/+ mice (n=4, 23.78 ± 0.03h, p<0.01) 
(Figure 3.8A-C). We also tested Cnot7-/- liver lysates to confirm that Cnot7-/- mice lacked 
CNOT7 protein expression (Figure 3.8D).  
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Figure 3.8 CNOT7 deficiency elongates circadian period. Representative double plotted 
actograms of A) Wild-type (Cnot7+/+); and B) Cnot7 -/- mice housed in wheel running cages 
for 30 days. In 12h: 12h LD conditions, time of day is represented by white and grey shading 
indicating periods of day and night, respectively. C) Plotted are the period lengths of 
individual animals (means ± SEM) of WT and Cnot7-/- (n=4 for WT and n=7 for Cnot7 -/-, 
**p<0.01, unpaired t-test) mice housed in wheel running cages for 30 days. D) Immunoblot 
of WT and Cnot7 -/- liver lysates analysed by antibodies for CNOT7 and α-tubulin.  
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4. Effect of Cnot1 deficiency on core clock gene expression 
 
We have observed that the Cnot1 and Cnot7 deficiency elongated the circadian 
period, indicative of their functional role in the SCN. To understand the molecular 
mechanisms that underlies such elongation in circadian period, we focused on Cnot1 
heterozygous mice. It’s been reported that a reduction in Cnot1 levels affected the expression 
of other CCR4-NOT components (Ito, Takahashi, et al. 2011; Zukeran et al, 2016; 
Yamaguchi et al, 2018). Therefore, to confirm such reports and assess whether components 
of the CCR4-NOT complex are affected, I examined their expression in Cnot1+/- liver lysates. 
(Figure 3.9). Cnot1 deficiency did not affect the expression levels of the majority of the 
subunits, except CNOT8 and CNOT9.  
 
Figure 3.9. CCR4-NOT subunit expression levels in Cnot1+/- (HE) and Cnot1+/+ (WT) 
mouse liver lysate. A) Immunoblotting against CNOT2, CNOT3, CNOT6L, CNOT7, 
CNOT8, CNOT9, and α-tubulin (loading control) in WT (Cnot1+/+) and HE (Cnot1+/-) livers. 
B). Protein quantification of subunits normalized relative to α-tubulin levels. WT values were 
normalized to 1. Values presented as mean ± SEM (n=3, * p < 0.05, unpaired t-test).  
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To examine how Cnot1 deficiency affects the molecular clock, I collected liver tissues 
every 3 hrs from Cnot1+/- and WT mice housed under DD for 36 hrs starting at CT0. We 
initially examined the circadian mRNA profile of canonical clock genes - Per2, Bmal1, Cry1, 
and Clock using qRT-PCR (Figure 3.10).  In Cnot1+/- livers, Per2 mRNA levels retained their 
circadian rhythmicity, but exhibited a ~ 3hr phase delay in peak expression at CT15 
compared to wildtype peak at CT12 (Figure 3.10A). Moreover, Per2 mRNA expression was 
elevated in Cnot1+/- mice during the subjective night (CT15-18) (Figure 3.10A). Clock, 
Bmal1, and Cry1 mRNAs all retained their circadian rhythmicity with minor changes in 
expression amplitude. (Figure 3.10B-D). Clock in particular exhibited a decrease in mRNA 
levels during the subjective night (Figure 3.10B).  
 
Figure 3.10 Effects of Cnot1 deficiency on circadian gene expression in mouse liver 
under constant darkness.   Relative mRNA circadian expression of A) Per2; B) Clock; C) 
Bmal1: D) Cry1 in wild type (black curve) and Cnot1+/- (red curve) mouse liver normalized 
against Gapdh using ΔΔCt method. Two-way ANOVA was used followed by Sidak’s 
multiple comparison test.* p<0.05; **p<0.01, ***<0.001. Values presented as mean ± SEM, 
n= 3-5. 
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Next we examined whether the altered expression in the mRNA profiles were 
translated onto the protein level especially that of PER2 and BMAL1 (Figure 3.11). We 
found that PER2 levels were significantly upregulated throughout the circadian cycle in 
Cnot1+/- compared to wild type mice (Figure 3.11A-B). Even though Bmal1 mRNA levels 
were not altered in Cnot1+/- livers, its protein levels were elevated (Figure 13.11 A-B).  
 
Figure 3.11.  Elevated PER2 and BMAL1 protein expression in Cnot1+/- liver under DD. 
A). Total protein lysates from mice liver under DD were immunoblotted against PER2 and 
BMAL1. * Next to blot indicate non-specific band. B). Relative protein expression of PER2 
and BMAL1. Values are mean ± SEM, Two-way Anova was used followed by Sidak’s 
multiple comparison test. *p<0.05; **p<0.01 and ***p<0.001). 
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5. Cnot1 regulates mRNA stability of Per2 and Bmal1 
 
The steady-state levels of an mRNA within a cell depends on the balance between 
transcription and mRNA decay. The decay of an mRNA is an essential tool that a cell 
employs to regulate gene expression and therefore adjust protein synthesis levels in response 
to stimuli or environmental conditions (Wiederhold & Passmore, 2010). 
In the previous section, we observed that in Cnot1+/- mice, Per2 mRNA levels were 
elevated but only to a restricted period of the day (CT12-18), while protein levels were 
significantly elevated throughout the circadian day compared to WT mice. To delineate the 
possible mechanism for the increased mRNA expression, we examined Per2 and Bmal1 
mRNA stability.  In order to so, we needed to inhibit transcription, so that the measured 
mRNA levels across different time points would reflect mRNA decay rate without the 
involvement of transcription. We used Actinomycin D (Act.D) as it is a known 
transcriptional inhibitor that acts by intercalating with double stranded DNA and therefore 
inhibiting RNA polymerase elongation.  
Initially, we generated Cnot1fx/fx embryonic fibroblasts from mice carrying a floxed 
allele of Cnot1 (Cnot1fx/fx), and then transduced them with a mock or Cre-recombinase 
expressing retrovirus to produce Cnot1 loxP/loxP: mock (Control) and Cnot1 loxP/loxP: Cre 
(Cnot1 KD) mefs. As shown in Figure 3.12A, Per2 mRNA became stabilized in Cnot1 KD 
mefs compared to Control mefs with around 3 fold increase in half-life (2.67 hrs for WT and 
7.74 hrs for Cnot1 KD). Similar observation was seen in Bmal1 mRNA, with a significant 6 
fold increase in half-life (1.59 hr in Control and 9.83 hrs in Cnot1 KD).  
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Figure 3.12. Per2 and Bmal1 are stabilized in Cnot1 deficient cells.  A-I). Cells were 
treated with 5ug/ml of Actinomycin D (Act.D). Relative mRNA levels of Per2 and Bmal1 
were determined by qRT-PCR at different time intervals after Act.D treatment and 
normalized to Gapdh mRNA level by ΔΔCt method. mRNA level without Act. D treatment 
(0 h) was set to 100%. A-C) Control and Cnot1 KD mefs. Relative mRNA levels of A) Per2 
and B) Bmal1 were determined by qRT-PCR at 4hr time intervals after Act.D treatment. n=3 
for Control, n = 2 for Cnot1 KD. C). Summary of estimated half-life. D-F) WT and Cnot1+/-
mefs were treated with Act. D. Relative mRNA levels of D) Per2 and E) Bmal1 were 
determined by qRT-PCR at 3hr time intervals after Act.D treatment. n=5 for both genotypes. 
F). Summary of estimated half-life. G-I) HEK293T cells were transfected with siRNA against 
Cnot1 and Control for 48 hrs followed by Act.D treatment. Relative mRNA levels of G) 
PER2 and H) BMAL1 were determined by qRT-PCR at 3hr time intervals after Act.D 
treatment. n=5 for both genotype. I) Summary of estimated half-life. All values represent 
means ± SEM. (*p < 0.05; **p < 0.01; ***p < 0.001, unpaired t-test).  
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However, this experiment was conducted on Cnot1 KD mefs, which exhibited 
reduced viability and underwent necroptosis, making the results inconclusive by themselves. 
Therefore, we generated E14-14.5 Cnot1+/-mefs followed by an Actinomycin D chase 
experiment. As shown in Figure 3.12D, we observe a similar stabilization of Per2 mRNA in 
Cnot1+/- mefs as that observed in Cnot1 KD mefs. The half-life of Per2 mRNA in Cnot1+/-
mefs (3.54 hrs) was longer than in WT mefs (1.70 hrs), and exhibited a 2 fold increase 
(Figure 3.12F).  Similarly, Bmal1 mRNA stability was affected in Cnot1+/-mefs showing 
around 2 fold increase in half-life (Figure 3.12E). Seeing that Per2 and Bmal1 were stabilized 
in Cnot1 KD and Cnot1+/-mefs, we wanted to know whether a similar mechanism was in role 
in humans.  
We used HEK293T cells treated with siRNA against Cnot1 and control for 48hrs 
followed by Actinomycin D-chase assay. The half-life of PER2 mRNA was longer in Cnot1 
siRNA treated cells (6.65 hr) than in Control siRNA treated cells (3.59 hr), a 2.4 fold increase 
(Figure 3.12G,I). BMAL1 mRNA as well was stabilized in Cnot1 siRNA treated cells (Figure 
3.12H) and half-life was longer in Cnot1 siRNA treated cells (13.86 hr) than in Control 
siRNA treated cells (3.87 hr), a 3.5 fold increase (Figure 3.12I).  
We further examined whether the CCR4-NOT complex interacts with Per2 and 
Bmal1 mRNA in the liver using an RNA immunoprecipitation assay. We used anti-CNOT3 
antibody to pull down mRNA that interact with the CCR4-NOT complex. In anti-CNOT3 
immunoprecipitates, CNOT1, CNOT3, CNOT6L, CNOT7, and CNOT8 subunits of the 
CCR4-NOT complex were detected, indicating the validity of the experiment (Figure 3.13A). 
Using this approach, we were able to detect that Per2 and Bmal1 mRNA are enriched in the 
anti-CNOT3 mRNP immunopreciptate, 19 fold and 7 fold relative to control IgG (Figure 
3.13B). This indicates that Per2 and Bmal1 are targets of the CCR4-NOT complex.  
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Figure 3.13 Immunoprecipitation with anti-Cnot3 antibody pulled down components of 
CCR4-NOT complex and mRNAs from liver lysates. (A, B) Mouse liver lysates were 
incubated with antibodies against CNOT3 and control IgG for 1 h and then 
immunoprecipitated with Dynabeads Protein G. A) Proteins in immune complexes were 
analysed by immunoblotting with antibodies against CNOT1, CNOT3, CNOT6L, CNOT7, 
and CNOT8. Arrow indicates CNOT1. (B). Per2 and Bmal1 mRNAs in immune complexes 
were analysed by real-time PCR (n = 3 mice for each group; *P<0.05; unpaired t-test). Mean 
± SEM. 
 
6. Cnot1 deficiency affects poly (A) tail length dynamics of Per2 
 
To confirm that the stabilization of Per2 in Cnot1 deficient cell is due to a disrupted 
deadenylation machinery, we analysed Per2 mRNA poly (A) tail lengths. To do so, we 
examined the poly (A) tail length at 4 different time points in Cnot1+/+ and Cnot1+/- liver 
using a poly (A) tail-length (PAT) assay: two during the subjective day (CT0 and CT6), and 
two during the subjective night (CT12 and CT18) (Figure 3.14). We can clearly see that the 
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length of the poly (A) tail of Per2 mRNA fluctuates throughout the circadian day in both 
Cnot1+/+ and Cnot1+/- (Figure 3.14A). In Cnot1+/+ livers, we observe longer poly (A) tail in 
CT12 Per2 mRNA than in other time points assessed. While in Cnot1+/-, longer poly (A) tail 
was observed at CT18. A detailed comparative analysis of the populations of poly (A) tailed 
mRNA at each time point was conducted by running the same samples with an Agilent High 
Sensitivity DNA chip (Figure 3.14B-E).  At both CT6 and CT18, Cnot1+/-, livers contained a 
higher population of long poly (A) tailed Per2 mRNA than Cnot1+/+ livers (Figure 3.14 C 
and E). While in the other two points at CT12 and CT0, they exhibited no change in the Per2 
mRNA poly (A) tail population (Figure 3.14 B and D). This change in poly(A) tail length 
dynamics confirms that the increase in mRNA stability observed of Per2 mRNA in Cnot1 
deficient cells is due to an elongated poly(A) mediated by a disrupted deadenylase activity. 
Interestingly, the observed poly (A) tail lengths distribution, especially time points with the 
longest tails were similar to the peaks of Per2 mRNA expression in both genotypes.  
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Figure 3.14. Per2 mRNA poly (A) tail changes in Cnot1+/+ and Cnot1+/- mouse liver 
under DD conditions. A) Representative gel of the Poly (A) tail length of Per2 mRNA in 
liver of Cnot1+/+ and Cnot1+/- mice collected every 6 hrs under constant darkness measured 
by poly (A) tail length assay (PAT). Distribution of measured poly (A) tail length of samples 
loaded onto gel for B) CT0 WT vs CT0 Cnot1+/-, C) CT6 WT vs CT6 Cnot1+/-, D) CT12 WT 
vs CT12 Cnot1+/- and E) CT18 WT vs CT18 Cnot1+/- 
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7. BRF1 (ZFP36L1) binds to the AU-rich area of mPer2 3’UTR and regulates its 
stability. 
 
The CCR4-NOT complex is recruited to the 3’UTR region of its mRNA targets 
through direct interaction RNA binding proteins (RBPs). It’s been well established that the 
3’UTR region contains multiple cis-acting elements within it that can influence mRNA 
stability and translation efficiency. Therefore, we aimed at identifying which of the known 
CRR4-NOT interacting proteins binds to the 3’UTR region of clock genes, primarily Per2 
and Bmal1 mRNA in-vivo. An examination of the 3’UTR sequence of Per2 mRNA revealed 
that it contains multiple AU-rich elements (AREs) AUUUA highlighted in yellow including 
the well-studied element UAUUUAU (Figure 3.15A), while Bmal1 mRNA 3’UTR region 
contained a few AREs (Figure 3.15B). For the identification of Per2 mRNA 3’UTR and 
Bmal1 mRNA 3’UTR RBPS, we synthesized the 3’UTR region in vitro and conjugated a 
Flag peptide to their 3’-ends as described (Adachi et al, 2014) and performed 
immunoprecipitation with Flag tagged 3’UTR RNA bait.  The Per2 mRNA 3’UTR region 
was divided into three constructs - Per2_1, Per2_2, and Per2_3 – as the technique used for 
fusing a flag tag has a size limitation (Adachi et al, 2014). The three different constructs have 
an AU rich elements in them. We prepared total protein lysates from wildtype mice liver and 
incubated them with Flag-tagged Bmal1 mRNA 3’UTR and Flag-tagged Per2 mRNA 3’UTR 
for 1 hr at 4ºC. RNA-RBPs complexes were purified by anti-FLAG M2 Affinity beads, and 
analysed by immunoblotting (Figure 3.15C). Of the examined known CCR4-NOT interacting 
RBPs, we identified the TTP family of ARE-recognizing protein, BRF1 (ZFP36L1) in Flag 
tagged Per2 mRNA 3’UTR immunoprecipitates. We found that BRF1 predominantly binds 
to the Per2_3 construct over Per2_2, and is undetected in Per2_1 immunoprecipitates. This 
indicates that BRF1 binding site is within the Per2_3 region. BRF1 was detected with Bmal1 
mRNA 3’UTR immunopreciptate, but only modestly (Figure 3.15C). Similarity, UPF1, 
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which involved in non-sense mediated decay (NMD), was bound but to a lesser degree to 
both Bmal1 mRNA 3’UTR and Per2 mRNA 3’UTR immunoprecipitates.  
 
Figure 3.15. BRF1 binds to Per2 3’UTR A-B) Sequence of the 3’UTR region of A) Per2 
mRNA (1880 bp) and B) Bmal1 mRNA (505 bp). C) Mouse liver lysates were incubated with 
Flag-tagged Per2 mRNA 3’UTR (Per2_1, Per2_2, Per2_3) and Bmal1 3’UTR bait RNAs, 
immunoprecipitated with FLAG M2 affinity beads, and analysed by immunoblotting with 
antibodies against Pumilo2, UPF1, BRF1, CNOT1, CNOT6L, and 4E-BP1(negative control). 
Mock is liver lysate without RNA bait but incubated with FLAG M2 affinity beads.  
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To identify which of the sequences BRF1 interacts with in the Per2_3 construct, we 
performed a sequence-specific competition experiment using 12 bp of Locked Nucleic Acid 
(LNA)-oligonucleotides (Figure 3.16). We designed LNA oligos targeting two AREs:  
Oligo1 - GAUUAUUUAAUA and Oligo2 – GUUAUUUUAU (Figure 3.16A).  Mouse liver 
lysates were incubated with Flag-tagged Per2_3 3’UTR and flag-tagged Per2_1 3’UTR (used 
as a negative control) constructs in the presence or absence of  the 12 bp of complementary 
LNA-oligonucleotides in the same manner as in Figure 3.16, and analysed by 
immunoblotting against BRF1 (Figure 3.16B). Binding of BRF1 to the Per2_3 construct was 
inhibited by competition from Oligo2 and not Oligo1, indicating that binding preferentially 
occurs at GUUAUUUUAU sequence. Also binding of BRF1 was reduced by competition 
from Oligo1 but not to a similar degree as Oligo2.  
 
Figure 3.16 Identification of BRF1-interacting sequences in Per2 mRNA 3’UTR. A) 
BRF1 interacting sequences in the Per2 mRNA 3’UTR. B) Mouse liver lysates were 
incubated with Flag-tagged Per2 mRNA 3′-UTR bait RNA in the presence or absence of 
12 bp of complementary LNA-oligonucleotides for 1 hr. Immune complexes were analysed 
by immunoblotting with antibodies against BRF1 and 4E-BP1.  
 
BRF1 has been reported to interact directly with CNOT1 and recruiting the CCR4-
NOT complex to its target mRNA and destabilizing it (Adachi et al, 2014; Akinori et al, 
2015). To examine the effect of BRF1 on PER2 mRNA stability, we performed an 
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Actinomycin-D pulse chase experiment on BRF1 siRNA-treated HEK293 cells (Figure 3.17). 
A knockdown of >80% of endogenous BRF1 was achieved by targeted RNAI (Figure 
3.17D). Figure 3.17A shows that Per2 mRNA levels were stabilized in BRF1 siRNA treated 
cells (7.01 ± 0.15 hr) compared to Control siRNA treated cells (2.76 hr) with a two fold 
increase in half-life (Figure 3.17C).  
 
 
Figure 3.17. BRF1 regulates PER2 mRNA stability. A-B).  HEK293 cells were transfected 
with control, BRF1 (102) and BRF1 (138) siRNA for 48 hrs, and then treated with Act.D. 
Relative mRNA levels of A) PER2 and B) BMAL1 were determined by qRT-PCR at 3 hr time 
intervals after Act.D treatment and normalized to GAPDH mRNA level. mRNA level without 
Act. D treatment (0 hr) was set to 100%. n= 4 for both conditions. C). Summary of estimated 
half-life. D) Immunoblot against BRF1 and CNOT1 showing siRNA transfection efficiency. 
 
The destabilization function of BRF1 is specific to PER2 mRNA as BMAL1 mRNA 
stability and half-life remain unchanged in BRF1 siRNA treated cells (Figure 3.17 B, C). 
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Together, these results suggest that BRF1 regulates the stability of the PER2 mRNA through 
the recruitment of the CCR4-NOT complex to the ARE within the Per2 mRNA 3’UTR.  
 
8. BRF1 oscillates during the circadian day 
 
BRF1 binds to the 3’UTR of Per2 mRNA, destabilizing it and promoting its decay. 
To elucidate whether this is relevant during the circadian cycle, we need to examine the gene 
expression pattern of BRF1. The BRF1 gene is under circadian control and rhythmically 
expressed in peripheral tissues such as the heart and liver (Panda et al, 2002; Storch et al, 
2002). However, rhythmic cycling of mRNA does not necessary translate to circadian protein 
expression, therefore BRF1 protein expression pattern during the circadian cycle is necessary 
to attribute a possible function for BRF1 in circadian regulation (Reddy et al, 2005). In 
wildtype mice liver, BRF1 is expressed in a rhythmic manner (p<0.05) with peak expression 
during the subjective night (CT16-24) and nadir expression during the subjective day (CT4-8) 
(Figure 3.18A, B). This circadian expression pattern of BRF1 is reciprocal to the oscillation 
pattern of Per2 (Figure 3.10A). Moreover, in RIP-qPCR experiments using anti-BRF1 we 
find Per2 mRNA to be enriched at least 3 fold compared to control IgG (Figure 3.18C). We 
were not able to detect any BMAL1 mRNA expression in anti-BRF1 immunopreciptate, 
corroborating the notion that BRF1 binds specifically to Per2 mRNA.  
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Figure 3.18. BRF1 oscillates in a circadian manner in mouse liver under DD conditions. 
A) Representative Immunoblot against BRF1 and α-tubulin (loading control) in protein liver 
lysates collected every 4 hrs under DD conditions. n=3 biological replicates B) Quantification 
of BRF1 protein levels, n=3.  Rhythmicity was assessed by one-way Anova. C) BRF1 
antibody immunoprecipitates BRF1 in liver tissue. Values D) Per2 mRNA enrichment in 
immune complexes were analysed by real-time PCR (n = 3 mice for each group *P<0.05; 
unpaired t-test). Mean ± SEM. 
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4. Chapter 4 Discussion and future outlooks 
 
An organism’s ability to adapt and coordinate its behaviour and physiology with the 
surrounding environment is a well-known phenomenon. This ability is mainly due to an 
internal time keeping system known as the circadian clock that is resilient and finely tuned on 
a molecular level to external stimuli (Kondo & Ishiura 2000).  The molecular clock is a self-
sustaining biochemical pacemaker that is governed by a transcriptional-translational feedback 
loop that results in a 24 hr periodicity (Ko & Takahashi, 2005). This loop is responsible for 
the generation of behavioural rhythms through the regulation of daily oscillations of gene 
expression. 
With the advent of microarrays and high-throughput sequencing, thousands of 
transcripts in different tissues have been identified that exhibit circadian oscillations (Zhang 
et al, 2014).  To maintain such strong oscillatory behaviour on the levels of mRNA, post-
transcriptional regulatory mechanism are necessary (Wang et al, 2018; Koike et al, 2012). 
One often overlooked mechanism in the field until recently, is that of mRNA degradation and 
decay. The steady state of an mRNA in any time during the day is dependent on the rate of 
synthesis through transcription and on the rate of degradation. One without the other would 
lead to deleterious consequences reflected in the behaviour of the cell (Collart et al, 2016). 
In eukaryotes, there are two main conventional mRNA decay pathways that are both 
dependent on deadenylation – the shortening of the poly (A) tail (Goldstrohm & Wickens, 
2008). The deadenylation of an mRNA results in the destabilization and subsequent 
degradation. This process is mediated in mammals by 10 known deadenylase, four of which 
are incorporated into a major cytoplasmic deadenylase complex, the CCR4-NOT (Collart et 
al, 2016). Therefore it stands to logic that the CCR4-NOT complex is a major regulator of 
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mRNA decay and that alterations to the complex can alter behaviour and physiology (Collart 
et al, 2016). 
In this work, we aimed at determining whether the CCR4-NOT complex regulated the 
activity of the circadian clock on a behavioural and molecular level. 
4.1 Subunits of the CCR4-NOT complex exhibit a diurnal and circadian pattern in the 
liver. 
 
In the first part of this thesis, we examined the temporal expression of the CCR4-NOT 
complex subunits to see whether they exhibit time dependent expression on a protein level 
under 12 hr light/12 hr dark (LD) conditions and both mRNA and protein under constant 
darkness conditions(DD). This was done in an attempt to shed light on a possible mechanism 
of mRNA decay regulation of thousands of transcripts throughout the daily cycle via the 
CCR4-NOT complex.  
We show that under normal 12 hr light/ 12 hr dark conditions (LD), components of 
the CCR4-NOT complex exhibit diurnal expression patterns. In particular, CNOT1, 
CNOT6L, CNOT7, CNOT8, and CNOT9 display diurnal patterns, while CNOT2 and 
CNOT3 were constantly expressed. When expression pattern was assessed under constant 
darkness, CNOT1 (although lower in amplitude), CNOT6L, and CNOT7 exhibited circadian 
expression.  CNOT6L and CNOT7 expression pattern were opposite from each other, one 
peaks in the subjective day while the other in the subjective night, respectively. While the rest 
of the components, were constantly expressed. CNOT8 lost its diurnal expression pattern 
when assessed in DD, indicating that it’s not under circadian control.  This was also observed 
on the mRNA level of Cnot8, even though PER1 and CRY2 bind to the promoter region of 
Cnot8 (Koike et al, 2012). The difference in expression pattern in LD and DD could be 
partially explained by the need for external stimuli to regulate CNOT8 expression and that 
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Cnot8 is under post-transcriptional control. Furthermore the inclusion of CNOT6L into the 
complex requires interaction with either CNOT7 or CNOT8 (Lau et al, 2008). Therefore, 
with the difference in expression pattern of CNOT6L and CNOT7 with minimal overlap, the 
inclusion of CNOT6L could occur through its interaction with CNOT8 in the complex, and 
thereby conferring its deadenylase activity on certain mRNA targets cooperatively or apart 
from CNOT8. The interacting RNA binding proteins of CNOT8/7 are different from those of 
CNOT6L, which suggests that the presence of CNOT6L in the complex albeit indirectly 
through CNOT7/CNOT8 is necessary for its enzymatic activity (Shirai et al, 2014). In 
addition, Cnot2 was shown to be rhythmic, but that rhythmicity did not correlate with the 
constant expression on a protein level.  The constant expression observed in CNOT2 and 
CNOT3 in both LD and DD cycles is indicative of the functional role they play in 
maintaining the integrity of the complex as well as modulate its enzymatic activity (Ito, 
Inoue, et al. 2011) If they were only expressed at certain time of day, then the recruitment of 
other components as well as their enzymatic activity would be affected (Tucker et al., 2002). 
Taken together this supports the idea that components of the CCR4-NOT complex are under 
circadian control in the liver. We did not test the expression in clock impaired mice, therefore 
we cannot with complete certainty conclude that they are clock controlled gene. Interestingly, 
Nocturnin another cytoplasmic deadenylase has been shown to be clock controlled (Green 
and Besharse, 1996). With that being said, we can stipulate that they are since they exhibit 
circadian expression on both mRNA and protein levels. Taking together the above expression 
patterns, raises the possibility that the composition of the CCR4-NOT complex changes in a 
time-dependent manner, and its deadenylase activity and target mRNA specificity is based on 
which of the deadenylase subunit is part of the complex. In future experiments on this matter, 
studying the endogenous deadenylase activity throughout the day by means of an in vitro 
assay will help assess the deadenylase pattern mediated by the CCR4-NOT complex. 
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Deadenylase activity measured in previous studies typically involved the precipitation of a 
single deadenylase such as CNOT7 or CNOT6L, or co-incubation of purified deadenylase 
proteins in vitro at single points of the day to show functionality of deadenylase (Ito, Inoue, et 
al. 2011). More research on the individual deadenylase activity over the circadian period is 
needed to fully generate a global picture of how the CCR4-NOT complex regulates mRNA 
decay around the clock. An interesting approach, would be knocking-in Flag-tagged 
deadenylase subunits, and examining their deadenylase activity individually as previously 
done with NANOS2 (Suzuki et al. 2010). 
 
4.2 Regulation of circadian behaviour through deadenylation dependent mRNA decay. 
 
Circadian rhythms generated in the brain, in particular in the SCN govern a multitude 
of physiological and biologically relevant behaviours from sleep/wake, hormonal cycles, and 
digestive activity to immune function (Ko & Takahashi, 2005). The SCN plays a pivotal role 
in synchronizing an organism to the external environment by relaying signals to the 
peripheral organs, which are in turn synchronize their internal tissue-specific clock. 
Therefore, changes to the functionality of the SCN or alteration to its molecular clock would 
alter the behaviour of the organism, desynchronizes the peripheral clocks and lead to the 
development of various diseases such as obesity and metabolic disorders, cancer, and 
cardiovascular diseases (Torres et al, 2017). 
Since the CCR4-NOT complex has been implicated in regulating every single step of 
gene expression, it was noteworthy to examine whether a deficiency in one of the subunits 
would affect overall circadian behaviour. Here we show that in the SCN, several components 
of the complex are expressed at a constantly higher level than known genes such as Per1, in 
particular Cnot1, Cnot2, and Cnot6. Of the examined subunits, Cnot7 was found to be 
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rhythmic. This implicates the components of the CCR4-NOT complex in regulating 
behaviour. This prompted us to explore the functional role of these proteins on circadian 
behaviour using multiple CCR4-NOT subunit knockout mice. Cnot1+/- and Cnot7-/- mice 
displayed elongated circadian period. This is consistent with circadian period elongation 
reported in Neurospora strains lacking not1 (Huang et al, 2013). Similar to what was 
observed in Neurospora, in a genome-wide RNAi screen in human U2OS cells, CNOT2 
knockdown resulted in an elongated circadian period (Zhang et al. 2009). Preliminary 
ongoing experiments of other CCR4-NOT subunit knockouts – Cnot6 and Cnot6l KO mice 
did not exhibit any elongation in circadian period (data not shown). However, in ccr4 
(CNOT6/6l ortholog) deficient Neurospora, the period was elongated (Huang et al. 2013). 
Interestingly, Cnott7 and Cnot1 deficient mice displayed similar elongation period, even 
though we had assumed that with a complete KO as in the case of Cnott7 (one that is 
rhythmic in the SCN), we would achieve a stronger phenotype but that was not the case. This 
corroborates the notion that CNOT1 is necessary for proper overall functioning. Interestingly, 
in Cnott1 deficient mice, CNOT9 was downregulated. It has been reported that CNOT9 and 
CNOT1 interact with the miRISC to miRNA targets (Fabian & Sonenberg, 2012, Chapat et 
al. 2017). Therefore, we expected that in dicer deficient cells, we would observe a similar 
increase in period length. But contrary to our assumption, Dicer-deficient mefs dramatically 
shortened the period (Chen et al., 2013).   
We attempted to explore the molecular mechanism behind the observed period 
elongation by focusing on Cnot1+/- mice. The control of period length is determined by the 
intricate interaction of the core clock genes in an autoregulatory, transcription-translation 
feedback loop (TTL) (Ko & Takahashi, 2006). CLOCK and BMAL1 form a heterodimer and 
bind to the promoter region of Per1-3, Cry1-2, and other clock controlled genes promoting 
their transcription during the day. Once enough levels of PER and CRY proteins are 
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translated, they translocate to the nucleus, form a heterodimer, and inhibit CLOCK: BMAL1 
mediated transcription. The repression on BMAL1/CLOCK complex is relieved as PER and 
CRY proteins are degraded by ubiquitin (Ub) dependent pathways. The E3-ubiquitin ligase 
FBXL3 promotes ubiquitination and proteasomal degradation of CRY proteins (Siepka et al, 
2007). Another regulatory loop is involved in generating Bmal1 oscillations that depends on 
RORs and REV-ERBs which are nuclear receptors that bind to the REV-ERBs/ROR-binding 
element (RRE) in the promoter region of Bmal1, regulating its transcription. RORs binding 
activates transcription, while Rev-ErB inhibits transcription. Together these two TTL loops 
regulate the transcription of clock genes with a period of around 24hrs (Ko & Takahashi, 
2006). Therefore disturbances in these loops would result in elongation or shortening of the 
period depending on which clock gene is altered. Several studies have reported that rhythmic 
PER2 levels are the key determinants in regulating circadian period length (Isojima et al, 
2009, Chen et al, 2009). 
In our study, we found that Per2 mRNA levels were significantly affected in Cnot1+/- 
mice with an increased expression level that was restricted mainly during the subjective 
night. The observed expression also exhibited a phase delay in peak expression of Per2 
mRNA of around 3 hrs. However on the protein level, we see a significant increase in PER2 
throughout the daily cycle compared to Cnot1+/+ mice, that was still rhythmic in nature. We 
believe that this increase in PER2 protein is mainly due to the phase delay and increased 
mRNA expression of Per2. Predictive models examining mRNA oscillations suggest that 
mRNA stability affects the phase timing of oscillations (Luck et al, 2014). To that end, the 
rate of mRNA decay of Per2 was highly attenuated in Cnot1 deficient cells. We only 
observed an elevation in Per2 mRNA levels after peaking time in wild-type mice (CT12), at 
this time point Per2 mRNA levels reach their peak and they enter their descending phase. As 
shown by Woo et al (2009) Per2 mRNA decay kinetics are different during the rising and 
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declining phase of the cycle (stable and unstable, respectively). So if the mRNA is stabilized 
it will continue to accumulate and not undergo degradation. This is clearly the case in our 
data. We see that a deficiency of Cnot1 resulted in in reduced mRNA decay and subsequent 
accumulation of Per2 mRNA transcripts that are later translated into PER2 proteins. 
To determine whether the observed stability of Per2 mRNA is due to deadenylation 
deficiency we examined Per2 mRNA poly (A) tail length. As expected, in Cnot1+/- the poly 
(A) tail was longer than in its wild-type counterpart. This is contrary to what was observed in 
Yoo et al, (2017). After replacing the endogenous 3’UTR sequence of 
PER2::LUCIFERASE fusion in mice with an SV40 late poly (A) signal sequence, they found 
that Per2 mRNA poly (A) tail was shorter. The difference might come from the notion that 
deadenylation processes are impaired in Cnot1+/- mice and not in the PER2::LUC mice which 
is why we could see a difference. Deadenylation impairment is quite evident in CNOT1 liver 
specific deficient mice, where the bulk poly (A) tail exhibited a significant shift of poly(A) 
tail population from 70 nucleotides (nt) to 150 (Takahashi et al, 2019). The elongation of 
poly (A) tail of Per2 mRNA in Cnot1+/- livers at CT18 indicates that deadenylation 
mechanisms are impaired and that aids in conferring stability to Per2 mRNA transcripts.  
The recruitment of the CCR4-NOT complex is mediated by its interaction with RNA 
binding proteins. The list of known interactors is quite incomplete, however, based on what 
has been studies the majority of interacting RBPS bind to the AU rich element (ARE) in the 
3’UTR region of an mRNA and recruit the complex for targeted degradation (Shirai et al, 
2014). Examining the 3’UTR region of Per2 mRNA using Flag tagged 3’UTR sequences, we 
were able to identify BRF1 as a binding partner. BRF1 (ZFP36L1) is an ARE binding RBP, 
part of the TTP family that is has been implicated in destabilizing its targets via recruitment 
of the CCR4-NOT complex. It’s been shown previously to recruit the CCR4-NOT complex 
to its target mRNA by binding to CNOT1 through a short C-terminal region in BRF1 (Fabian 
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et al., 2013, Takahashi et al, 2015). Interestingly enough, BRF1 shows a reciprocal pattern of 
expression to that of Per2 mRNA, with peak protein expression during the subjective night 
when Per2 mRNA levels are in their declining phase. Knockdown of BRF1 resulted in an 
increase in mRNA stability and half-life of Per2, and that was specific to PER2 mRNA as 
BMAL1 mRNA stability remained unchanged. That suggests that BRF1 binds to the 3’UTR 
region of Per2 mRNA during the declining phase, and induces its destabilization by 
recruiting the CCR4-NOT complex which in turn shortens the poly (A) tail and results in the 
degradation of Per2 mRNA; thereby controlling or better yet fine tuning its mRNA 
oscillation pattern. Therefore, in Cnot1+/- mice we believe that the molecular mechanism 
behind the lengthening of circadian period is due to an impaired deadenylation dependent 
mRNA decay of Per2 that causes a delay in PER2 protein levels and thereby slowing the 
clock. Previously two other Per2 mRNA 3’UTR binding proteins were identified, KH-type 
splicing regulatory protein (KSRP) and polypyrimidine tract-binding protein (PTB) (Chou et 
al, 2015, Woo et al, 2009). Both bind to the 3’UTR region of Per2 mRNA, and destabilize it. 
The redundancy of these the RBPs ensures that the tuning of the clock occurs in a precise 
manner and thereby not shifting behavioural rhythms.  
 To fully understand the impact of CCR4-NOT mediated mRNA decay on circadian 
clocks a comprehensive and systematic approach should be taken. Initially, circadian 
transcriptomics data of Cnot1+/- mice as well as other CCR4-NOT components that are 
expressed in the SCN is necessary. With the identification of thousands of oscillating 
transcripts, availability of several RNA-seq analysis, and the information that can be derived 
from said data such as transcription rate, mRNA decay rate (mRNA stability), and steady 
state levels amongst others we could get a better understanding of how deadenylation 
dependent mRNA decay tunes the circadian clock. Furthermore, in line with this notion an 
exhaustive list of RBPs that interact with CCR4-NOT complex across the clock would aid in 
81 
 
illuminating how thousands of transcripts are targeted for decay by the complex in 
combination with RIP-Seq identified RBPS, would explain the “How?”, the “when?”, the 
“who?” questions that come to mind when working on regulatory mechanism of mRNA 
oscillations. Furthermore, we need to generate a complete list of RBPs that bind to the 
regulatory regions of the core clock genes. The method use in Flag tagging the 3’UTR end of 
mRNA allows for an easy way to capture the RBPs in an in vivo setting (Adachi et al, 2015). 
When starting this project two years ago, my working model was as follows: The core 
essential components are constitutively expressed throughout the day which includes 
CNOT1, CNOT2, and CNOT3, while the other deadenylase subunits interchange depending 
on their RBPs and target mRNA. With that, we could possibly explain how CCR4-NOT 
deadenylation dependent decay occurs around the clock. 
 
Figure 4.1. Working hypothetical model of how the CCR4-NOT complex targets mRNA that 
oscillate at different phases during the day. Schematic illustration depicting the possible 
mode of global mRNA decay throughout the daily cycle. 
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